var title_f19_43_20144="Trabeculations HCM";
var content_f19_43_20144=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Apical trabeculations in hypertrophic cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 234px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADqAXYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5gmlIJY8s2R8w6UtlFJdTpArqrMepYAfmavaFpVz4i8S6do9iB9pvbhLeP5c8u2Nx9hnP0Fe5fGTwJoHh/SdM1jw5YQWdilxLpl1ulWcSOhJjl3ZbBdQTjjHFAjE8M3+naRZrBPGpuVGS6PGQ3FFr8RVsdcDRTyJAvb5c59+K87a9SI7YgjKT8gUAFT9cVlecZrrdGHD7snLDn6cUhWR9QaN8YWdBGbxXjbAV24I9ulbv2661ZPOttVAbOSqvgD9K+a/DrXrTEqGdkyRskwoHuMV6tpF1K1kJBK0DrztDON36U7Cv0O4uJdUSJyupRrhScvISH/IV594h8WamJJI2uFYL8pcO2B+lY/iO/kuwbf8AtF0ckjIZ9o9ulV7SwEFsoe7hkJXmM78n36UrDKev639s04R20u6XuA7Zz69KabLxNY6Zpl5c2FzJZ6juNtKCz+btJBG1ckcg9QMjkZFPl069abNjZl4SQfM2vj6GvUPDnja102z8HDVbLVkn0OWYywxqWikR9+1l3OPmXdgAjgZwR0osB5VDoN14g0+dotMlLxLvJhgmbGRkFjg445zXMav4L1qx0DTtZSBrjTb6OaUSW4d/JWKQoxk4+UbgcGvevAnj2100ifWINWu9Va7SY3EIa582JVC7D5kg2sMfeGeOOMZrFk+I+k6HYaZ5tr4hS702PUkSxMKJaXJuZJGXzT5mcKHHG080MpM8A/srU203+0Psd0tk7bVufKbymPpvxtz7Vbl0LWLaKKefTr+OORC6O9u4DqBkkccgetesv8YdLfwnY2S2t5Hc29hbWUtg1tHJa3HkMpB8wvlASucbCQSfmog+JGiy+KtV8QFvGd/pV+LkahBKI2i09LhCg8r5yCQWCgts4AGCaQzzDTvD2qappGrapEiwW2m2yXMgmypdGkCBk4w3zH+dV7Twz4inv7CyTR79J9TlSG0E0JiWZmwAAzYGDkc5wBzwK9J1r4keF38JXOiada6w8P8AYkGlRtcLEpZ0ujKSxVzgFe4BweMd62NY+NPh0WumpotrrQFlrdnqixTKi7I4wRJH5vmM8jNkjc3UEg47gHjuqeHtU0myuXv4xbT2199gktX3eaJNpbI42leMZDHPGMjmqzaVqdrefZLjTL6K4MfmiKaBw+3+9jGce9erT/FnRYLszWkOsamy+K4tfUaiqKTCsLIYsh2wylgF6jCg8dKswfF3RbS5sls5NfuBa2eppHf3YQXQmugNgG1ztRCAd27JJyAOlMDypNH1k6ibEaXqH20qHFv9nfzWXHULjOPwqpdpNa3ckF0ksEkfDRSgqyexB6V7Jofxg06KTS5NTl1aaWHRY9LvZJLdLn7QwmZ+SZUYrggBg6kHsa8r8bavaa54w1TUdOguLayuJjJBDPOZXRcY5Ykk9OmTjpzipGfe3wYcyfCfwkzdTpsP/oIryn9s8D/hENALHAF6/wBfudq9Q+Bhz8IPCP8A2D4v5V5j+2gP+KJ0X2vif/Hapko+TdPtpnsLq/LE21qy+YqsRvLdAfy5qnd6hNdyrJNK7EAKMkkIo6KPampd3CWtxapIRDOymRfUr0/ma3Ph94UvPGvjCw8P2EtvBc3fmbJJ87F2Rs5zgE8hTSGYQmyBgnPUjFNZgQ5RvzHWun8eeDLnwdcact1qFpexahbC6geBZEbYSQN0ciq6HIPUc1yuGVmUEZXvmgBokcsASwx6dqWPLEKRkdRil2ZAIXPtQpYkE8Hpn+lADi23cgYquOQeaaXyqhdygfdGe9OkwEC9x0PFQkbT1zQgHByBndz2poyWxnk9aXB34b6GiTG87AQB+NMBRIxYknJPrTmm3EEj8RUYBIJ/OnAgkgbV4xQIkjieRykKl3wWGOMADJ/Sot7KrJxgnn3pMYHXp0xSHPrQA7eehyT05PamkDJxx7UAE4A/nTlXOMDOex7/AEoAVDkFf4f600DKnnB75pzJtLcHjvTM5yAOKADqelKMgcHGaaPxx3o5JyfzpgPDABgV57EdqQsTTckdDSj0HQ0AOY8FCQSD1/pTc0ZAU5GSRx7UuAB6/wBaALdluLn5gBjPJwaKhiCnO5+TzxRUgb2hatHo1yt7aG8t9Rjc+VcW85idOMEggZHBIyD3rR02/iurC40lby5tLKdxK8P2hhCzjozKBhiPU1zdzJJ5hkjkyucFunXsRXQeHtNGoQn7RGS45UqxGPc8VQjMvoHsx5VvcqUbPCMfm/wpthue4RZZgmQP3hJOPxxT9Z0s2UrCQ/MOnJ+b6cVBpsEt7OIoyQpOCOSBj1pAes+A7VrbabaCWdW7wlhlvU+tdhr1vrF5D5Fvb3tur8GSRXwfpis/4ZeDR5CzAu4LAhtr5/nXsFpfwacgtriKM4GAzKTj8zTJPnq5+Hmq387Hz4Gx13LIMe1dT4Q+H1gjxtqcq+cnZgwz+tdZ4r1O2tP3u9xuzjbAME+vWvE/F3iueXf5Myqm7G4IB+XNIZ71qK6FotssKXdqhHJwucfm1eZ+PNa0a82rYyxyOOd0ajk/g1eJ3+o3U0mWlLjJHJ5FbPg2wvLu9VlhZow2WJQEH2GeKBnZQyTQxeZYOhX+L9yp2H2Oa39U+HvirULSxn1G1WKK9Tfb/uULyHsCM5Bxzj0Nei/DfStLDLd+JrjTbaxtm3CB0j3TN2yAM4H69PWuu8efEnQNU0C/0vSbi8luJk2JPb4iCHPckggHoeOQSKYkfLWseEtH8KytP4oujf3in/kE2Dqpz/02lGQg/wBldzeuzrWJe6nqvijSNSIe107QdHjW4TTrZTFbqzSLGoAGS8h3E7nJYhW+bjFdH4uESyNZrJEZM9fkP64rI1q1OkfDS2hQbZdY1Brl9vUwwKY4/wAC8k3tlB7UikcPHGkjqrPtJBy1aMWhT5UySRpExGG3g4HqayMsQAcnb0GOlSiR1BCs20jBUknNIZ0V3pGkW+1HvwZOp25wT/3zUdp4ba4uNonjS36rM2Sv06VgfMz8Luzxn+lTeaQqBmdlXtk4BpBY6UeFogWMmq220dR82cflWXqthAjb7e5EiDjPf6VQ88tvZ2O09u9PgdSQME85PGeKAP0F+BH/ACR7wl/14JXnP7ZiO/gTSNh5+3f+y16L8B/+SPeE/wDrxT+tefftkoG+Hmm5HS/Xn04NVISPjNvmc7sY9fSuo+GXjEeBPHOm+IRp4vRZCT/RxL5W/fE0f3sNjG7PQ9K5fkgh/lIGcDvUZGRknHv60hnbfEbx7/wmFloVpFYz21vpEUscc15eG8uZvMYMfMlKruAI+UY4Ga4g8DAGOf8AOaaP4iB0/SpEDcDJGR270wHDBBByR32imyybuCACoxiiNgCC3XFDKrZZQQeuDSGISpXkkgDgfzoXghgvXjr7U3BKk8D2/wAKUE5UFscdaYgxyOMEjnI/WhlUtw2T9KcR6EkZ4JHP/wCqmL97JxgehxQA0DJx0Ge9OyoG1uceh70rAHLDJGelSeXFk/N8vb6+lFwIDnHOcUoHOCQKtx2NzdLm3hkkx2UZq9H4d1VEYvp9xtIyMxHmgRjnAAwMj360AnnPFWri0mgf5opFbOOV61Vkx1J+buPT2oAQkt+PakY5xwB/Wgjvzil2HkjoO/rTAaKM8YoI5wOaSgBfSlPGc5pKKADPr0pwyOucf0pAM5JP596dgHG3GO+e1ADoS24+Wdpop0BGcN0AopMCe4DFJApA5GQCTiup8B6ybS5aCYl4zxjc2D7cYrnkiSa6kEjeSvqc4P5Vat9LTfskuokYnhmDYPp0FFxaHXeJdL/tG4lm023wi88Bjt/OqvhnwteXF1GpgdZWcLsZW5H96ksNMu9OG9Lv90R8xVWII9TkV12jap9lQM1+JVJG0mM5HsfahEnuHg/T5PDWlKrWvmSY42qcH8CawNX8RT3l26Taa6NuwCYRwPfJrEtvEep38KSQX9rF5eQIynQVzPibxzrNoyxSw2rjOQwjHz+9Gg7j/iLqkq2KRGKZIzkMxtlAJ9ua8Rv7oyTHcCeeFwMfp3rpvFHi241RVZiykZDgRrgemK4yUkqQMEsc+9A0WLDy5byIOWWEHnoT+teyaBe6XZiP+z3USAAspaPA4/nXiUDMkgPOCcPgCupXxDZ2Nug0+B1l/hJwRn16UXBo9e13xbbf2eqi4gjzwybo9zfpXnd745ltZGa3IL9NyOMY/LrXF3+tT3rl5ec/exgZP5VViSWWZV4JYgYJ9e9AJdz0/wAD6D4i+IeoXsmk6at8LUK0yi6ijKbs7T85BOdp6f4V1vxT0s6He2en6nplyogs47O3LqypLgbpNjbcH947ng9xXVfspWLaR4iv9xCRXVjg5b7zIykcY7AtWL8ZPF93rfjSe4VVOmWSmKzzu4Hdz7sf0CjtQI8B1qx+w3APlNGN3CHkj61khmBbPIPqOa6rXrie/aSaYIZD67jurmJUZGDEceuMA+1IpCEjYMHJ9MUFvkTj5qajZBXoDzxQU24J+uaBj4nHfgeo7mrFsES5ViFYA5xUBKKSyoG/2uoqW3AcrhT1yATSHY/QX4Atu+DvhY4/5dAP1NcJ+2Odvw4sTjOL5O/sa7b9nog/BzwxjtbY/U1xv7YY3fDWzH/T/H/WqkSj4tVUAYNuww4B4NKltLK+xULEjGQK0NLigluNsrHJPy5PU+1e4fC3w3p63sUtzbq6jBwRnFJajbseU6d8P/EWpWyTWelTtGR8pKmotQ8Da5ppJvNPnjVeu5SBn2NffGkC3W2SOGNVjAGFAxmn6vp1pqdnNDPDHICMcjNVYV2fnlB4c1O6vDDa2Msr9kRSeKtXfg7XrKPzbvSbyNOfm8lufqfSvvnwp4VsdFtsW9vEshOSQoyPxrVvbjTrVGW+ngiHcSEciiyC7PzWltZUTMsLIxPdSMU2WGQMF2AYA4HevvnWtS+GyOf7Tn0MN33BCK52TVPg5CPNabRCAc8KDzS07hqfF1np91dybbaCWVs8bVJz7V1lr8L/ABhd26SRaHd+UcZZoyMfpX1bY/Ej4XadIo097BQDgtFCBXqnh7VdO1vTUvNKljmt5BkFfShWC7Pzz1rwFreiIkl/ZSxI/wDeGCDXqXwQ+Ci+KozqGtO8diDhQv8AH617F8d9Ke6mtIooXMMhG4oM8+ldj8N7JtJ0WC1jTywFGVxwKLCv0Leg/DfwxocCR2Wl267BwxXJ/HNWNd0PS3snia2hCk4wFAI+ldMCxUEY/wAawfEciwWryMQpUfeqgsfNHxV0OxsWYxog2H6cen1rzWwttCluRJexwqNv3M4BNdF8ZvEbS37QQuZCvO3+7mvF5Z5cEKWVTz16mpuCR6Pqmi+Grtgtu3lv03K3JNc1deFAk5W3u0ZQOpI4zWBb3b7sSMzHuSc/lWjDeOw3LLiYg/KTgY9/egEixL4O1ID5VVsjIArI1LSL3TiPtMDBD0cDKn8a6jR9Q1HKl3YInTOefQZ9K359YRwIb6NZVxyMfcHtQFzyliGJPSkr0XVfCVjfWhvNMlETdfLP8Xt7VwV1aS2p2yKRzye350wuQKSDwAfwp6bl5XGf51GQQSKXGDyKBksUW8bmK7frRTo3kH3cH3J/SilqB2V54QmaJJ4JlkRjnOT+XSsy50PULdQ0iKFJAwzE7feunhOo6baOPMaW1ZcY3n5TWBfatcTllmZmAYDBZiHGKGyUjofDOgapLH80MMttu4Dq5J+mK9U0P4Ptqdv5olFsGGSqo3H5968/+G3ii7sdSjiETSxnopc7V9q+o/C+rG7tYpI4GQY6YPWqQWPF9W+DV2s+ywmuWcfxMPlJ965bxJ8Jdc0+xdzbJcADllViR/TFfWryHy3ZoTu9hXBeO/HB0PT3AtfMkI+XKEjHvSYWPi/WtLvLGYpc28kbDjlccfjWUoXc7BTtC8dK7Hx54uu9f1CcyiNIcn7kYGD6VxLuxbJADdwBikMWViw9AO2KYT2Bz9aRjuIz19SetJTGPBB+8SD69q6vwPdWUGpCW7DuQQQu4D8eRXKBiF2/wn2qSGWWF8xSbWA6g9qWwH0Jqfjk6ac21x5KvGY8RyZypGCM47isDVPFum32nuruvHBLO+fx4ryJtQuGRd88jKpyoJzg+tGXmJaWUkN154NK4uU072aF7xlilEi55kG78sGn6vbqwiQff8vkEHA9/rVKz4kIHLDp15966TQPDt3f3Syyuyxnj5w2WHpQPY4d12P657jvQDuADElQetew634AtbmzY6eqRzoOQobj6V5lqWkz2UkizoVdMrtwRwO9MEygVwxGCynnGP1p9vKIySrHDYBBHX2FNidth5AbOMetAB3jJ6njg4qSj9A/2eTn4OeGef8Al2/qa5H9sIf8WvgYHBF/Fg/nXVfs4kH4M+G8doSP/HjXMftgAH4VxHHP2+HB9OtVIlHxTFNtO/jIPbt717n8FfE1sZoorudAQdqhzXgz5DMrYzniprW5lgcvE7Rk88evtS2G9T9B9I1m08ktHKpUdWzWL4j+IVlpEUvzguvRK+PbH4j67Z2LW8dyNuMAEf5/Os2/8SX+phVuJyc859+9F2Kx9xfCfxqfF1tcyEj923GB1FeMfHnQvF174qkazt7uezcDY0OcL9feqH7MnxE0Xw7Jf6frtwtqZcNHK2dv0r3XV/jL4G09dz6ok754VEJ/pTuuoWfQ+Rk+GnjS7DMNC1Box1BTk+9bWkfArxtqVvvNituvfzX2k/hXr3ir9pfTbJSmhaa87Z/1kjYXFcPd/tIeJ7mAfY7e0iYnj5c4/WlePRDsyLSP2b/Fc4xd3FrbKDxuYn+VfR3wh8FXXgjQTYXV4Lkk5yOx9vavIfB3xk8WXUaNqUMcmeQRHjPPTrXpuk/EqWZd1/ZiIHnj0pp+RPzPSbi2huABPGr46ZHSqF3dWmnvHG7qmemTXJar4/UQkWkJVj3PPNeW+LfEs9/vlEjmVTg/Mf0ouB7brHiyw0ywe4knTao9eleBfFL4yQTQNb6c+4sCCAwGB61wHirUNZuoHj8x8MflXkgj1rij4S1rUZfMjtJn3DOSDzRqwujA1vUpb24MrMx8w5Yt1NYzndnJB5+8Oleu6N8GNdvwXmhMKdeTnFdNZfs738isZroJIRwAM96aTC6PntFJIxj057VJ86DduGTXvE37Pt9EXMt6PUcfeNc5q3we1GxaQibIU7eRxj60WC5w+n6vJbl4JXiYBQGdeQw9M1rtP51vG8aBueAewz3qhfeCdTtZMrExUHHTNatrpGp2FovmQyNzydp6+3rSC5We+mgtm2b1BP3fT6e1XtMFneqIrxVJcd+3/wBeug0zR571U+127hgMkleAPenap4GeaNpdNZ1IbAHOfxp2Fc4bxD4a2TqdPTgjI/2h/jXLz28ttKY50Kt/tV6ZpLy2GopbagCArbWY54+le/3vwd0Lx14Stp4CsF80e5Z4xnB96ATPjODG449OlFdZ4z8Eax4H1mWw1iBo1z+7mX7so9Qf6UUmUj3WGyto7GSCKeNtv3o55gST6ZIrzPxnpcUkjPAY1l7Irf8A1q9A1fxZolxeqbQvFP8AebLDH4cVo6XJY69EElEW/ry6gn3PFPcg5H4caY9qI5GtV3E8jzC24+vAr6O8IsRHGuxEHfG7r+Ncn4X06G0nCqu1c/K6T7+fTGOlen6egUKUB6cg9KdwSJ5XIjOSB357V4h8bbiFLYxvIFLkn7jHp6Yr2vVGC2ztIBjGSc18y/GfUraXc6DeRkcytge1SymfPurrm+fZtJOeNpHNZ0pyAAq8cZGctWjdFWmd5IsMTlUXPSqDhvMwsYznsDzQhkiWE0sW+Mb8DcwHUCmvasind8rcYDd/pW5hjZp5dqqDHPyfe+vNYpw27gRqDzhen0oArlRg47dzTkjOMsvHQUrDaR0PcDtigE8DLBT93igY4J5YIJBB+9/9anxea0sS52qeFyeAKcEUEszDd+GKtBiFLJtUJ1JIBOaQHr3wz8J6fLbpcX9xHyckGTv+A6V6tZ6LojMTHKGYDHEhIA9q+XtG1qaCVVNzKsYGcrIQCPTFeh6H4mZpvMWSVYxjAaYgg+4xVXIaPY7rQNOjCyQqqFedxZufrXk/j/w5aXkk0lrKryLy23cS3tW3N4wSeFoGlZAV+6Hb5vxxVbRrGNpmu5ynlnnmRjwf60biPDLuz8m6ZXGB93oRtqq6qcYXLZwOOK9L8f6Rb/aHntERY+pChjn3NecyL84HC56fh6VJaZ95/s1/8kZ8Pc5/dt/6Ea5v9sBsfC2EZ66hDx+ddF+zSQfgzoBXgbX/APQzXO/thY/4VVFkZ/0+L+tOQI+IpeCQpyKI8lSS3C9iOKR2DHgDGOgHSkJIBHQHtQMkKc55GTyO9WRbsCHUbR3JPHT+dVQOrHORz7VYhZnwqj5+y54FIBk33tqZKt92pRv/AIi/PAINdL4Z8KXGt3cUYbarYyQOn0r2rQvgZbyOpml8wgAkAcf/AK6dri5j52hsJrmVY4IJGkIyVUEivTvA3wn13VGW6+ymKInb8w619O+BfhVoeilZ0tFaTsXGa9Hi0+3iyUQD6DFOwXbPB/DHw7vrNo1nddsZ+7jpXdWnhDzIgsyAqDkDivQRbx8FQD+FPKYXngjvTFY89vfBULJtRiHIwSOlZkXw5s7ZZXkJlJGcHt74r0q6uIbcL50sUe7pvcL+Wazrqf8AeCNGXzSNxTPJX1xQFjiYfA1hLFE+wfIcAkcmui0/QbO1TCQRq698fyrRt5d0YKlcHjcrZwR2qeQxrCSwJ9OelAWILcRRhQUVcDI9/rVO/wBQjtYnK5J5x71Q1C5zuZSV5/E1mW8FxdyMJW3pzkgfypAVr2+u9Xh32oZcnnPaoo/D19ewiOeQ4kHzAjoPWu40fTo7WBAIwBjp6/WthEQgEA9hwOlFgsecaf8AD+OOPZMfMLfxEZyKuSfDqzZcNg45XI4FejxLjtg9D7VJtGOgp3Cx5PJ4CeM/IgaPuvSs+Xw29vM6FVG4HJA6/SvaCAc5FVbm0hnVlKjP8qBWPnvxB4Dg1WPCqn2leQwwPzo+Fni648Ea/wD8I74gd/sEzbYZWGNjfX0r2K+0hLN/MCgqRyBXAfFbwdD4i8PSTW4C3MY37x6DsKQbHq2r6DpGvpGdUsba9VcMhlQOB9Pzor53+D3xrTQLSfw/41Zx9jH+j3ABYsucbTRS5rFctz501FJNzyQSSYDfJnGQfeuk8CeKb/TL+OOVt0edpHG761UXxi5Rre4toT6Hylz7Crnhu+ikuBdzOg2HJAVOBmgln0T4M1mW4kjLMvzYYruHyj6V69Yyb4l4+UDj3rxTwFqdnfLGbCZRgDIYpnNezaSx+zKHbeTzkYpgin4rWWXSJ1SXygVO5gcEV8h+OoFgvZ/MlWbk8ZYk++K+xtYhSe1ZHOOPXFfL3xN0e3TWJX+0kR87j55z+XpSGzwuaSQXTeVGZAuTkqxzU6JLewlre2RCeGOSNlX9R+yQuwS8kVTwGE7Hb+VVmnhtYmKXscgbqDubd9aAuNi0i3liIkmxL/vE7qz7mGOKUIHwvQgqcCteJdNEDSi4+YrxgNgH0/Gtr4a+HtO8V+L7XS72KVIpY5HPlsVYkCgLnDvbFVwyBQOckcn60xUeN2Kqee23t7VcvR9g1mUQqrGC4YDcCwba3Gfbivomy0Cx1nxv4Y8YW9tCNPn097mZAg2LLGnOR0/Cgbdj5oclCODnsWAp0IOCSTtJ5OelTa7It1q15dJgJNM8mAuMZYkcVTjADYyVboOKALiRt5oUZO3nAI716R4Y0u8urJHjhKlxgmSQDI/KvONLmaC6SQhXXOF3YxmvY/DWv3FwqQ277nxhlj2DA9RTJZG2h3UNwnm3SBQMgBxkD6irF8kzyJBHcOI8dEnIKn34r0TQ9BaSQPdykO+GA8xTXRNp2nwIVKjd3cuo3UCPGTPZyqbe6Y4H3/3rHd+lcJ4k8PLA5m00ebC2eWLfKPyr3LXtQ8P2NyI0MJnORnzBx+lOsPst7bmO2VGDjoX6+54pD2PUf2alK/BrQVPUCQH/AL7Nc/8Atg/8kk46/b4cfrXefCDT30vwJZWkmNyPIePdya4T9r44+EvX/l/g49etNlI+H8bsdAfr1qQwsVUqc5461CMs2OeT2rf0eB2mjVlDuCMKB1pBczrHT7q7OIomYDtjOPethPDN9bJFJdIIxIeB3avpX4aeA7JdIhvr2EIX5AZeT9ad4q8OWd/qZggiwF5yO3pinYXMzzfwRdLpsaqsaiYAct29vrXtPw/8UpdGKFR83QAnJJ9646/+H8zbHto2MichU6H3zWp4d8I6vp08U6hlK9xwTRYVz6AsLpHgDcD196tiQOpKkZ7VwX2m6RoCyP0AK/3Se9a0WpSOwjKEHufXigZ04kxgD9TSOTkdCcc+1ULSfzHAyWOOTVgOD1yB2zTA8U/aC8Oaz4g8U+CBoWj2+qGCDVPMF9atNaqxgTYJOgVmIwhJA37T2rk5NM1zw54O8CeKPCuh65PrOn2MukXthPbSC4KurFSV258tJeQQMbStfShA59eh9/pUbEBgTnIHpxQM5DwL4bfwr4K0nRnO+4ghzcNnO6ZjukbPfLFqt6rHMIQY5hluT/tCp9b1AWkW6RvlB6+v1rzvWfEy3FzJDFI4AOHYdF+lK4jooBJNKE+9JuxnqF5rs9I03yYx8o7dO1YPg2NLmESnB44H+NdxD8qYA6dPegERiFSMdj69c06OIKCobLZznGKlK9CSR+NNGFIGevSgYqgE59elPPTJ4qNsk9cg8cda5/W/FdtpPjDw14dnhmkude+0+TIoGyPyIw7bsnPIPGAaAOlqP5eBzz39a4TUvihpGlP4yj1G3ureXwzHHLMjgZuFkGYzFzzuOF5xgkZrtrKRrmxt55IHt3ljWRoZPvRkgEqcdx0oALlEnUgjcB39DXJeI0ltbZ0RMqQeMgY9669cCQcjp26VmeI4DNaFUyXAyPf60CPgr4rWTweK7h/mj3kkds0V9G+PPANrr0UEphVJQ53MQfTpRSaBOx8iNIFmdxGhz8p3KcL9K19FsTM8cTxDJ+YeWByPxNZPjDTl0fxbremIxdLK+ntgx6kJIy5/Sqqy7Y0VGKPgHOKAsfQPgmzv4pIjEysp4DbVVh+VfQfhH7fHaot5I7D2A4/Kvh7wv4q1KxvFaG4xwAcoDj3r3v4XfErUrm7Fveyl7f8AhyFGfencVj6A1MS/ZnIIBHYkfnXy18Wp4I9RmF3dMjZPKOpwPSvqG2v7e7tifNRtw5OQfwr54+Mel2k2oOUiCyMTgArjPrmkxs+fNZWxyBb3UroTwrAcVlxPEMq6FiBywatbW7NoXZiihTwSGGT71kDIYAKMjoSelAGkJjDAkkSI4HTc3Sur+E3ia00Px3baprc/l2aROpdQWI3DHSuDYSYO9iY885bqaiZzkgntgUAd546sfCEcVxe6Frt1eXks277M1vsUKxySGpfDfxQ1jQfDE2gWqwy2MiSKryKfMXf1wa4AsecZx3GaTJznpQBMpXLbgSBwO+KcgXG4x8Dk5B/zioYgCcdyelSFU37d4x3bB/KgZpaVD9pnXdGWTvtXt7Zr2Hwhp1jbyxzPatHIOUG1QP514tZXMluW8o7Mnk46Cun0HxK8HyXb+aMjYvlg5ouS0fQP9tSwx7ImKgHA+4M//Wrh/G/iy4hjZItQYPnLqjJkfSuU1zxDJdWQIJhUDkGNRj0A55rgb6czT5LsxXOOBQCO50Bhc34uLu4mYt8wDyKK97+HYikkDl/k7Zdecdq+avDcksV0oESu5AwGIGDXt/gyLU0RXaYIpxkArQNn07oOP7Mi2nIye+cc14/+2Fj/AIVCf+v6H+tepeCJGl8OWzMSSS3JIOefavLP2whn4Sf9v8P9aGNHxJbKS25XUEetet/CfRo7q7ikmVSnVehx7mvHh6ivdPg/LCdKUs5Dluo7+3sKBM+krKeL7GsJxs24JHf6UWWnLNqG7ykwvCtgYIrjPDmsRtcNDLuIBGxj0X2rr9O1B0vTGyMFYZAI9+tMR3Fvp1vHEoCA4HXFWILaJGbagz3OKq6fdNMmW3ADjnvWhG47daZRBPZxSMdyAkdKiWxiR9wHPr3+lX2fccDjnrTGPX6UCKYAhOAoHekEnmHr1/WrMiBtuOvrUKxAHjBGeSO1ACBjkcnOO/aqWp3XkxNtJJ9MfrV2Qqq7mGAOwrmtW1WMzOqnAU4B7/SgDmfFOpPHDKXGCOp61xHh+2n1zWUUQlIzn5sYGPf3rqPEBlvnEaKN79T1210Hw+0ea1tma4ULk5AIwWweppCOs0HT1s7OOJBtXHJxyTW5FuUcnjufSq6tjAB9t2KdvwnzE4z+VMZKHySPlyOcHvRgbRhuvcd6iMikjA59+3vTA5wR7849PagZaVgFGT83r6VxPj7wVqHiTxJ4Y13Rddj0fUND+1eUZbH7UsnnoqHI3rjAU+vX2rrvMyQAOfY9asRkEDnv6c0CPNPFPwoTxL4q8Pa9qOst59lBDDqcMVttj1TynEq5Xf8AIPMBOPm4wM8Zr1DqOODTATg44A9ulPzzSGIqKM8CobuNXhfeeMVI5PG3PPeq93IFt2JHbnJ6GgDm7+1RkAAG3dkZoqWylMyOrA4zuGf50UXEfnR4kv21XxFqmoSZ33d1LcNn1dy39aoAlgASOBwT/Kkflj9abQMs2rhJlOeMjJA5Ar1z4dzeE5HEOo/aXlfBIKZBPtjpXjyPjGVUgHPPevQ/AF/pNvOkggkEuRvKoTg+1AmfVvhSy0mK1EmmQkIV4+UgfrXAfFm+j8po2tZI8HAbYv513/gu4kn06PaZDGwzgxban8VeF7TVLF/Pg8yQr97aCT7UCPinX5WNyxDMwyc8jj6VgsxbG4qcjAzjivRPiBo0On6hPH5EuxTnBQAAV53OVDER7ueu7FJDQwO2AM8CnMVK9XJPr0zTY2w2T1xxzTnVQDtYEHkc0wGsWyxJ56HnrSErj0/HpTSc/Wg/pQMejhGztDDGCPWnKTyw6dAev4VFmnck9SAOaAJw22NlcgEjGCM4pbKOSSYCLIP97aTioEVnbgFj/Ou08PaTZJbCe8mVWcYIXd8h9DigTMu9tStqiAM0gGSXTjHr9ax5WVeAp3L6r1963/EU9v5vlWUMYZQQcA5I9c1z29y+NmT0A6UmCNXSfOEiPG5TkFn2g/hXqXgy/nuLqNPPlfB2+WiDAx3ryCzaSSYc/LjBGOBzXovg/VHs3ht9PhDSbtozHkn60Az7X+HOf+EQstwIb5s5AGefavNP2wgf+FRkjtfQ/wBa9I+GPn/8IXp5uuJmBZht2456YrkP2ltKGsfDr7OecXUb/lmmxo+BBnIx1r3D4HX1jFbP9o2q2cNkdfp6143qdr9jvZYATtQkKfUV2XwpNuNWDXMpAjOQueBnvQJ7H0Lc7Y2S7sAu7GVQDGPrW74Y1O+v75BLtAxgkjmktmtrjT4xHExV+gUcn3q9pVo0UgKZUjgnFBJ6Day+WsQfacj7v9a0EfK7hn/GsGCZjBGWxhfUcir9tMvlELk5P4fhTKNRJNwJ4Ax1x0pQ4G3IPvVKKYqeG6Uok5XgnnHPrQBc3At3A6Z9aYcjgnJHTHakRhu4/H2oOMHHfoM0AVr+VVhJ6k9R3ri9WtXumlkjwex45P0rotUkIddr/L6+/pWfDuJPycZ/AUgMPQdOna6/fw4Cn5Tnp9a7y2gWKJVAx6kHpVW2j2DkDJ5+vvVuOQkZPY9T/KgC1Gw84DPbpT3O5WG38O31qBPmPzcEfpT84XIPTnFAwVSMlTyTjPrT8BWYEnPXjotRmTeeD9fQ0+POdvBzyP8A69AgjG/0x/P3qyowDzk9z61AmM5J4PGak3boyMc/y96YFhGHToKXAYZINQKeOBuyOnrTmlCJy3Xv6UAK2FBzyMdcVS1adUt2DdAOPerW9XQsOuM/SqV3EswKSjIPXtmgDjdZ16PSraNwwRXcruPX6UV5/wDHi/SwaxhhkjGGPU47dKKlsLnxvL/rGxnGe9NpzA7jx3plMYp61c0y6a1vI33Oq7hkqSOKpU4bcgnkdxQB9kfCvxBaNo8ESSTY2DllbOfqa73Vbm7ks3W2uRG7DIZoy3FfPnwnurNLOFZXu/NA6h2wBXs+N1kWtbhskfKHJPakyUz5t+Lb6l/abi4ldkBJUlMBvwryhickH19K9Y+MU9ydQmjumg68bQeteTscnJoQxtFOA+XJ6Z60lMYU5V3HJzjPPNNxxntSqOaAL1tZJI21p0Bxngj9aWe0SOMNhivTduHH4Vf0lbFGjNwkrRg5428muoudT0p4QtrYvJcEYIO3pQTqcKkiWxBVcsOQd/GfpST6hPKWG7arcFVJANdJL4V1i9YSW+nukZ5j+den51h6to1zpxzOm3H3vmBIP4UDVjPEzAgkkkdyetOUBjgHG7nPOFqMqRwRz1NPiGSFycE4xnHFAzQtXjTlgrAcbcnP1zXpfw1eFr6JvsaM4bCuwY5rznT9NlmOLcAnPDF8Z9q9t+F2l3NiI/taxqMjC+bgikSz6t8CMzeFbAuApKn5cYxzWZ8Vbf7T4Y8ojKtKuR+dbHg9Nnh61HJ4JyTnv61R+IcnlaErHH+uXqfrTH0PjX4k+EorWSW4k8uOVwSR047fjXn/AIYiuItRTY+wA9cdeeleyfFaE33mSykiND8g7DFeIzTyWkzlHGASDg96QkfSnh3X2sdOwZlkdhycdDjtXoPhDU0urRpJCNy9VP8AOvl/whrDzxpGsgMg5zzxivaPAEc8so/elkPIBPWmI9civoXVC7/Ken+1WvatEE3A4yM8fw1yosw6K0zCMj+HHC1uaWYo1UK244/Ogo1owpywBAJ4H9aY82COTgHk+tEW9UJ5xnA+vpSlN3UBRg8envTAnt5lIIB57Z7fWlnmxE3uO3XNY8l2LNgcgbmwc96w/GvjK20XTXkdwZCuAFpXA03zLMcupXPTNbFtGuAeOmQMV5V8P9ffXpmlUvtdvkyfT1r1W2D8B2yB1oAnQfI2Rt/pUjgBVAXp1po3MSDzjkH2p/JAP8AxgdyaAGMz5xkf/FUsTMT29PanKo25wffHUUMuWG0EHv7UASMwI5657dqapOeR1/X3pqbjt3DOe396nbdp5btjOelAEqPnaMg46GpdykYVhg9OehqsAMDjoelKFAO8ZPrg9aYy0eR8p4/nUc6iQ4Y4wOcfWjOBhmA4pkgDDO7nrQAi3Kxoc8AdD6isbV9bWxs5pSCAqlifTFXb+VVhbLgD+IV4j8a/GkekaaLaCRRcPxgH+H1qWwPCfix4nu/EPiq4kkyUjOETOAB60VyFxIbi5kkldsMc7u5NFTcpJlSDUZ7GQ+X88RzxIgIJqa81a1ukG+yjEnQsqgVkiZs84YDoG5ApjHcSeOfSrIBypY7AQvYGrltp15crvgi3Be+4f41Rq5p9rd3EgFnGzuey96AOy8Dahq+l30MKTBEzwjOMV9K+Hb6+utMAmaPZ0LebXzJo/hzxMLiKeO1kyWxuIB+or1rSrjxRb2HlM8KlRwG2jA9+adiLnNfGLSpBObia5SQH+Hzfu+leKuCrEEc5r1n4jyaxNGzX1wApwGCspDV5ZcgZO5ssMAYPQVJSIOgPPFNrT022sJz/AKVcPEOnGOtaCWGircqgvmdM/McjGPbincZzyqW6A1f03Sby9dRa28krk4CqpOa9p8G3fw20yNXvLffKp4Mjlsn37V3Q+LvgPT42W0tRuj/55wjj6UaCuzyHwp8I9d1iUNMi2sH3svGcn2xXrOi/CLT9JhE13NG04GMrDjHua5Pxb8dxcK8WiW/kr2dsg/lXmOp/EPxFqRYvfMATyASM+1K/YfL3O98fQyaWZre01CQIDgnyh+QryyW0vr+ZRCJriQjbnyffrUdtrMr3Ky34N3z913PBz1r1Pwddy6lgR2tnYxZAHyFmaiwbHm8fg/WmlQGylVWbOSB+BxXVaN4TgsnEmrNsUjkbRkGvXW0KB7dpS5mmxyyqwXHoK4HXNB1DUNQMdvFuydhIhJAHbn1p2FclTUdOs3jhsI1knIzlVXgeteheBYHu5I7idHA4I3bQSK4Wy+Hup20atFHGHzwWjJP/AOqu/wDCuiXemvuv7hd/dFiIx7CnYVz6G8NY/sW229MHj05rC+J6o+gQrLnb9oQ4HrzWx4SIPh+0I6EHHGOM+lZnxIaJNCiaY4UTrz780iuh4f430ZLrT5ZNyiPHfqx9BXzJ4sjaPUPLOAozgen419U64y3iP9pgdUAwD2Ar5l+IsPka1IFUqjE4z396BIyfDd79kvsNykg2ketfVPw1kilgjaParlAGx0INfIAJByDg17V8DfE3kS/Zru4yFICKTzQNo+oXs4po0852HoKtacsNqpRTu96z9OvYLqMMH3D+I54J9qme7SN22AbvfpQB0lu25WLbTzwB/OlkUEdSR1+tc+NYht4S8zBR2BrDvPiJpiSmLzV35wcEcUAaniqz3xlmm2RDJZh29q+aPi54iUyraWzMxU4x1/E19DajfHVbIrAchhx6H618u/EnQ75fFMjGFjGz4344PtSYj3D4CuJdAjbyy0vG444P0r2mIExZPBHbpj615R8Drc2mleUzAHA+UD7vFevgfu2yTk9c96YyMg7lznb7VI5xgY4xye1ORTjkj2Pt6U3OCVOfQA0APWQO4VQDx/nNOZcLkYAHT3piABQOOc5x3p5kC8MKAFAbHX6+1Jsbksu7jP1oL4Bzy3Ye1MSXd0xg+9AEpACDHXrn1NOQkJnGG9fSo4/nOeuB+VSZ28A9f1oGKUUnBGSOcZ/WoLgBQwLfl3p8pKo21gGPGa53xPqy2NmzKVDAZGf4frQIyPGmu22k6fIZpVV9p2ZPQ18cfEDXDq+qzTNKpj3fKDyf/wBVdr8XPFk2pTrbxynCsdxB+9Xjt1JuAkY5lJOfYVL1KQ+GZdzBx83v0xRVSNVf+MhR+dFJpDIGGCcdKSlPU0lWSLViyuJIJR5UjRkkciq9FAHo+l67qphURatEAOiGHOPfrWnHZ63q0P8AyESCfmDxwkhvbrXkwYjoSK3NG8T6lpabLaRSvYOM4+lKxNjpNc8GeJFHmPHPPCDliE5WuOvdLv7ZyJrOdM88xkV6r4I8XeIteuEtEeBASOTAWH1NevQfDm81i3JvryzO8c7bfkfTmmkFz5CC5DblJOfvCuj0rQbaeNZJ7oJuXKglQfxr6Om+AGlzJlbkBzkjanH5ZrmfEfwO+x2jNFqNrsQZ5tsk/rRYLnhWsQ6fAzC2upZmPDgEYJrFJyflzx0ya6LxHo8GnyvFJdjzIzhlW32j8DmucYAH5TkUFCsd3PPvmlUrjJHPp2xRuwmFPHQ5pCfU544oAmk2BcopAOB161q6Dr0+myEplu4LSMAvsKwycgcmgMQc5pAex+F/G89/OIrvd5LHYsaswC+5r27w/LZw20bbYUYjcqiRmJ9zXzx8MbC4upUl890jZtuBIoyfSvpXwn4fGyKTzXfgZO/P4VRn1I765u7vKWEMSswwXO4irnh3wtdPOlxqMwkIPCjI4ruNPskTAdQT2HYVqIqgbU7eh70FWNHRIVg0uCNBgAdPxrlfi5uHhyExjc4uF4/OuxsgBaxAelcp8U3ePw7G0YBInXj160mM8pklnnsMyjci8IuMl6+evi/A6akJSiojMflPVTX0Mk6NaOzlt3Qrn+VfOXxivmm8Q/ZSxxCM7fTPrQJHn9WLG6ks7qO4hJDocjBxVeigo+jPBHxY0yLTY0vnEcwADK3b/Gu3i+KvhyO3aW4u0DH/AJZjkmvj3NBOfWkKx7V8Rvi4dSLw6LvRTlfM9hXkf9rXxnWY3Dl1bcOeM1RoxRYZ9DfBXx4L+ePTdTc7hyCT1Ndx8UNPE0AnsYcsBySOBXzt8KYQ/im2y23LY3egr7ENnFcaWEl2kbOD3oJZ5z8H9Qu7K88u6LEMMKvr9a+gLORZIsucEjnnpXg1/FNoepGa0UvyTnp+VemeEdf+02kX2kgT4GQTmmCO2bBOO+OlNCEDOQQB1/vVXiuFfD547c8mpomDLnIxnn0FAx2G38YwO/pQBwCM5/lTgDxkYPseDTGye2cHp60DEliBX5gSPc/rTbeMKCcZb8qkeYRjD4z65qJrlFPTaMdPSgC0hVQAoxjmoJZ41RixIAPJPUGs68v1hUkfNyM1xnifxpa2YMbt8+Mj0oFc6bWNbitYy7Px3Ar59+LXxAnuJJLW0+VNpCkn731pvjb4iRLbYhk3MeiE859T7V4lrmvm+kaST/WMeeOAPakwRRmnaWYzSy5B6lj3rMnkaaRi3GT0Hb3pssxdhkkqOlC8APyCe9IoIgOmSvv60U6N+Tt+6OMkUUmMgbIY54pKKSrJCiiigApyOyNuU4PrTaKAO7+HuvyW2pJHK7YB5ZASzD0r6s8G67Z3FpFiSUEDOGU18TaQgkv4185oCejhsY/GvePA8LWwjEF9NyvIafJJ9cYppEt2Po5dZgWMtvOz3Bz0rhPGfxF0bToJElWKRgDkMCQKp4uGh/5CTRkDJBfI/lXjnxWjuEtzs1BZV67SQce54pMVzivH3iW01u/MtnZwRICcAR4yPf1rjCc+lLKxZzuYMRxkU6AK0sasAQWAP50FDCuAM9T2pDXffGXRLHQvFtvbaVCILd7CCXaO7MvJ/Guy8C+ANG1TwAo1OLGvatFNPp7biBGsY4wOnPNAXPDwCTxzWtp+jTXQV5FkiiI+8V4/U1RcCC4KtEN0ZwVbPJFWrrVJ5YPJAQR+y80Az0TwfdWmjXMZ+0Syc/OPlIH0FfQnhLxvp7WsSIZGcgcbAABXxdayOr/u+HPYCvZfhjCs5iE8zhhj5dp/l6UE2sfUCeIIJ4wYt+e/TJqza3DuScsFOCMY49q5nQdNhZgqgeYFBYlO3tXbWlqlvEcopwMjA60FHR6d/wAeMGQR8o61yvxRt5LrRbWKI7Sbhcn2weK6nTCzafbs2clB1GK5T4q3DW+gRMrbSZgP0oYHm+p21rZ2QQuPMXkd8fWvkjx5N5/ivUJMk5fvX0/qiPbwRzSOZVdSQGPJ+tfK3imVJ/EN/JGcq0poEjJooooKCnBSc4B4602tS0t0Fqru5DyHCj1oAztrDBIIB9qQDIzk8d8V0um6Ib0JumwQMkY9fSl1XQDZSHMgJAyB2/OkBQ8MahJput200B5DDvx9a+vvDGv2V5oEMk1yDNsAYHvXxnc201uwcggHuK6bw941udNspLV8sG+6552UCaPfPHesSXGnr9iI+XOCP4a870r4hXOh3K/aXdgONp6j3NcdL4xunLIsq/OMfXJ61QuUbUUSOEFnJyX9c0CsfTfgz4qLqZ2MUO4csDxXrOharb3NvgSDf1xnp9a+EY11DRWWaANGEwWwM9K9J8H/ABJayiVr2RixIwDn5qBn1z9sUL/FycfSoZb6P5xvII4z714Bc/GGzdowk4RWGCc9K0JPiDZPYea11HlE3Ahxj6H3ouFz1e61B3lVVznHPpVe6vfKQ7mHPQk9a8ab4xWMdiWYKzqeuea4nxb8YWv2MVk7KC2WYcY+lAj2PxZ4xg06DaJ1z3bP3fYV8/8Ajfx9NdXjRWygoTxlu/rXFax4jvtRuMvMzKpIUZ4PuaxpAS2S2eM59/Sgdie9up7uYyzOzO/Q+oqvI7OcucnpSM2TxwOuB2pvamMPWnA4UjvTT1pVBzle3OfSgCxCERj824Y7D+tFNhiaQkgE/hRUsogPWkp8gAdsEEZ7dKbVEiUUUUAFFFLQBYsBI13F5RIbcMEdq9i8Gwao08Zk1GYKOvIGB7cV5FpV3LaXAeIZwQSu3Oa7yy8f39kqq0YjMfcxjBH5UEyPb3sleydbrVJwD1BkUH69K8S+JdhaW8kktpq/2jJwwabJb26Uur/Ei9vLfak+2F85/dgNmvPr68lup2adw5J5IHX3pAkVWGPTn3pAcEE80vGeKQUyj1zxX4w8D+JTbXWpafq8l/HaRwExyKigouB9a0Lj4zw6bfaLb+H9MgbS9OgjhElzGPO/28HtXidGeaBWNvxrqFjqnijUb7SYpYrK4lMkccnVc8kfnmsT2oOO35UueMdqBlrT1Rp03AHBzznn2r1/4c2SGWGRbpVbd2Zsle4ryG0kdiqhQ+0g4LEZHpxXsHw/0xp1SZkitljILFZm6f40Ilo+hfDFxBaEIZI2JHLAtx9a7E6ipjUpllPQjPNeWaKsMcuIrlmkzkfvCc/XivQtLkknhRcfJ3OTwfagEdxpUhl063kPVkBNcX8YJUi0WyaQnAuAduM54rtdNXbYQD0QVxXxhSN9Ds1lxjz88/Sgo8W8R6wP7LubiRtkKRscjv7Cvle5k824lk/vsW/M19C/FxEtvCErxyqAflAB+77Yr51oEgoopaBioMsB710F3b+VsjBDMoBBH8q544zxwK7rw7bWt5Zxh5QWUfvCTyF9qBMo2skzL5duC0gYYHTbXQWekzSWwW7Vip5Hrn1p1zDplhuaC5j3dge4HrWbaeL2N3DDOqm23hGbPP8A+qkIg8aG2s447eI7nI+Y46j0rizjtn2HpXr3xg8Padb6JY6pZTAzOBujB4UGvIVUu4VRyTgUxo7f4a+Br7xffhbYMsan5mr6O0D4MWtlbK9wR5oHRegPrW58BvD8OleDrSfy1E8qAs2OcY6V6q4xgAZHp6U9hbnhWtfCeKcfunXy1HCY6n3rxr4i+FZ/DYYyQjycYEnTH0r7Rlt1djkZXucda81+MWhyap4auoYYAWKErkdOKQWPiCRy7fJuxnIGc4pH81AVcuAecE8GtCysJjrUdlscyiXYqkdea9K1vwzDa6bBJeQhAR16EnHakO55FkkHk4pO/FdzL4ehmIjhB3EglR0Uf1pbrQo9NT94oZmHQjr/AIUBc4+C1eTDMCq559TUU7ZcqDkAkcdKt6pcK8pjjAAU9R/L6Vn9/SmMB7UUCjtyaAEp6tgEDg03tSnjjORQBYtZzGSDuPHbiiq6sQcjr70VLRSZ9Ea38OPBt23iCx0/T9X0ufS4ncXs7boHK+pPY15B8OvCp8XeKodNkmMNqqtNczrzsjUZJr1CX4t2+qat4ysPEF9LceHr2GUaejRltrfwdsiua+FPiHQfCnhLxFfasWur69C2UdnFLskMR5ZgccfX2pp9SNdjkviR4X/4RHxVcaZHMZ7Xas1vMRzJGwyDXLV6l8WfEugeLfDvh6/0oG01C0VrOWzdi7+WMbWLY5HGPxry2mMKXt2opKALFoYRcKZywj77ByPpWys2kyofOnuh/sBMj69aw4GVHDMM47da05Lu3YDy3RD3Pk8+9FhMq3i2Yx9mklYE/edMf1qkRgnnP0p8zB3LDAz2AwBTD165oGFJS0lAC5Ix7UEkkk9etLnpnnFPOFRdpy3tQBHQOvPSl6dKOAOCc0AauiSW63cfnFyR0+cKv6ivVPD/AIg02BYojcBC2NsauPzJrxX1q7p80cFykkis0Y7ccn/Cnclo+svBWoQyT4sopHkYjc5YfN+let6XcCKEec20n+HI4r5M8N/FFdMQRrbFFXac5X5fpxXaJ8a9OjyVhlmdgGGcAE0roSufV2lyCXT7dwchkBzXCfGkkaNYcEr553Y64xXRfDjVRrngTQ9TCeWLu1Sbae2RWJ8Xgp0qxJIBExIJ6DigrofIvxtvmWGzskO2Jjv2Z6+9eR11/wAT70XniqfbJ5iRjaPauR4x70DQlLSUUALV7SrtrWViM4IP4VSx6c16T8DPAI8b+Jwt2rf2dbYeXA4Y5+7mjcGS+C/hrrvjedZbONoLEkbpZBgEe1e6aR+zl4eggUXlxPNOQMsMAD6V7Voul2el6dHa2ESwwRjaoUYArSVcOMjA9P609hHivi34GafquhizsbuWKVB+7L9M+9fNHi/4c614O1LydQtpHhVxtljX5Tz1Br9BsDcd3Q9KyvEWhWeu6dNa3kaSB1IViPun2oYWOZ+GMqzeDtM8pQmIVGD24/nXYqOQQeK8y8H6pH4a1GTw/qEixtG37rJxuHrXpVtMk0YZeQRyc9fpSBEhjYsxJ4/lWNrSBraZSMnHTHX3rZmlRF6/SuG+IXi/TvD2jXNxJKvmhSEUtyW9qGB89+GPBwuvilcys/7pJCxJ43euK9N8deCv7Xt0FvKFKAYI5/AVxPws1I6r4gvdRlkwSxYjPQV62dTWSZdnLj+H096SEeSxeDpdOtU3xksD8vHI9zWD448Nvb6S8gjaWRhkH+Jvwr2bX9RhjVFcod55rGuIzqTlhEh2jCk/wj0oA+QLqGSCZlmRkfPQjFJFbyyKzRxsyr94jtX1Jd/De01uZE1G1Cpu3DbwRXNfGXwVZeEvB4/sW3wZGCyyDkkUx3PnvvzQRg8HIpVPOTzSGgYlOB9+KbS4oAsQNgsRGG7YJoqEcHKnH1oqWrhoDAlmOPc+1NI9j7VYuP8AWP7n+lV6aASiilH3T9RTASiipVA+zucDORzQBGOvTNLjitDTf+PpP92tS3VTbx5APJ6inYm+pzVFaOoKu9zgZ55xWbSKHDbg5BJ7Ugx3pKuXCqsTFQAQw6CgCr0PIx/SlZME8g+nvU2ASMgUXXX6HFK4iDpgj+VJxj3o/hH1qSIDFMCMdacF4Hoe+KUD5/xNW7VQSMgHp1oHcgjDDDbTgdDj71SI6AqMA47nPHtW6vFkgHTaRWXGq+dL8o4HHHSpA/Qf4H/8kh8I/wDYOi/9Brmf2lL8ad4RtZzJsxI+BnG75eldN8D/APkkPhH/ALB0X/oNeb/tkEjwNpmDj/SW/wDQacgPjK7ma5upZpDlnYsTUFFOTknPpTAbS0lL2FAABkivuv8AZ38KQ6B8PrGQoourxfOmbHPPQV8O2QzdwA9C6fzFfo94LUJ4Z0kKAoFunA47U0I3Ui+Uc8D0qTYB7nPU96mX7h+n+NN6EY9aAuNIwo559MdKbtxEeD34HU1aABHIoUADgUAfPP7U2j3EWh2HiHTmeK5tZQsrLwSp6ZxXm/g3473+nWUdtqUPm+WMBh1HFe//ALQyg/CvVcgHC5H5ivggElhkk5PPvUyGj6G8QftCvcWfk6dbFJSOreteP+IvFmteIroyahKXBz8q8j2rBthlxnngf1qzaqu2EYGCMnj3pWGenfBSby9UZYycbeAf4vWvcnso7iWNw+xu+OCTXg/wbAGrykAA/L/OvTb+4mXxdsWaQLgcBjinsQ1qcl8UL6/0TUQ1nKJQxO4Zzt9q3PCPiKWWytp9QhMXIGOmRXLeNPm8awqeVJGQehrofGQEfhNWjAU46jikB6/p+p2N7b5glWRtuMjqfaszWtLi1yMW90hMf3WQ/wANeV/B6aRr1FaRyvPBY+te7WKr9t+6OevHXiqWuoWPE/iD8OtNsdOjk0zTI3OcsoH3vU187+ILSGz1B4oSePvDHCn0r9A/EcaNpc5KKSE4yPavgzxMoPiHUMgHDPjI6U2C3OcFFL/yzz71NCAWkyB/k0ihiKCORn6CivRfBVrbtaOzQRFuOSgzRSaJcrH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The apical four-chamber echocardiographic view (panel A) from a patient with a hypertrophic cardiomyopathy shows heavy left ventricular (LV) apical trabeculations, suggestive of apical thrombus (arrows). However, on an ungated computed tomography scan with contrast (panel B) no filling defects suggestive of thrombus were seen.",
"    <div class=\"footnotes\">",
"     LA: left atrium; RA: right atrium; RV: right ventricle.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20144=[""].join("\n");
var outline_f19_43_20144=null;
var title_f19_43_20145="Organ reservoirs of urea";
var content_f19_43_20145=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F58368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F58368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Schematic figure showing urea stores versus perfusion in different organs during hemodialysis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 256px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The different tissue compartments represent areas of the body with variable degrees of perfusion from the heart and urea sequestration. Within the gastrointestinal tract and skeletal muscle, the ratio of blood flow to urea content is low. These organs therefore sequester up to 80 percent of the total body urea, leading to urea rebound and reduced dialysis efficiency.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20145=[""].join("\n");
var outline_f19_43_20145=null;
var title_f19_43_20146="Mechanism of acute pain";
var content_f19_43_20146=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F74589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F74589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mechanism of acute pain",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 398px; height: 532px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tissue injury leads to release of inflammatory mediators with subsequent nociceptor stimulation. Pain impulses are then transmitted to the dorsal horn of the spinal cord, where they make contact with second-order neurons that cross to the opposite side of the cord and ascend via the spinothalamic tract to the reticular activating system (RAS) and thalamus. The localization and meaning of pain occurs at the level of the somatosensory cortex.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wolters Kluwer. Copyright &copy;2008.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20146=[""].join("\n");
var outline_f19_43_20146=null;
var title_f19_43_20147="Olopatadine (ophthalmic): Drug information";
var content_f19_43_20147=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Olopatadine (ophthalmic): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?8/2/8228?source=see_link\">",
"    see \"Olopatadine (ophthalmic): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9502830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Pataday&trade;;",
"     </li>",
"     <li>",
"      Patanol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9502831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Pataday&trade;;",
"     </li>",
"     <li>",
"      Patanol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F9502836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist",
"     </li>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist, Second Generation",
"     </li>",
"     <li>",
"      Piperidine Derivative",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F9502960\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Allergic conjunctivitis:",
"     </b>",
"     Ophthalmic:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Patanol&reg;: Instill 1 drop into each affected eye twice daily (allowing 6-8 hours between doses); results from an environmental study demonstrated that olopatadine was effective when dosed twice daily for up to 6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pataday&trade;: Instill 1 drop into each affected eye once daily",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F9502959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     <b>",
"      Allergic conjunctivitis:",
"     </b>",
"     Ophthalmic: Children &ge;2 years and Adolescents: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F9502961\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9504109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic [drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Pataday&trade;: 0.2% (2.5 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Patanol&reg;: 0.1% (5 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9502833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F9503432\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     For topical ophthalmic use only. Wash hands prior to use. Do not touch tip of container to eye. After instilling drops, wait at least 10 minutes before inserting contact lenses. Do not insert contacts if eyes are red.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F9502885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     Treatment of the signs and symptoms of allergic conjunctivitis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9502742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Patanol&reg; may be confused with Platinol",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Patanol [U.S., Canada, and multiple international markets] may be confused with B&eacute;tanol brand name for metipranolol [Monaco]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F9502893\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;5%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Cold syndrome (up to 10%), headache (up to 7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Pharyngitis (up to 10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &le;5%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea, taste perversion",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Blurred vision, burning, conjunctivitis, dry eyes, eye pain, eyelid edema, foreign body sensation, hyperemia, keratitis, ocular pruritus, stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cough, rhinitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome, hypersensitivity, infection",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F9502889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to olopatadine hydrochloride or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F9502890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Contact lens: Not for use to treat contact lens-related irritation. Solution contains benzalkonium chloride; remove lens prior to administration and wait at least 10 minutes before reinserting. Do not use contact lenses if eyes are red.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299786\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9502897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F9502886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9502887\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     Adverse effects were observed in animal reproduction studies when using doses greater than the equivalent maximum recommended ocular human dose.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F9502888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F9504111\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Pataday Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.2% (2.5 mL): $143.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Patanol Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.1% (5 mL): $160.20",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10961997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Allelock (KP);",
"     </li>",
"     <li>",
"      Olopanol (KP);",
"     </li>",
"     <li>",
"      Olopat (AR);",
"     </li>",
"     <li>",
"      Opatanol (BE, CH, CZ, DE, DK, EE, FI, FR, GB, GR, IE, IT, MT, NL, NO, PL, PT, RU, SE, SK);",
"     </li>",
"     <li>",
"      Pataday (IL, SG);",
"     </li>",
"     <li>",
"      Patanol (AR, AU, BO, BR, CL, CN, CO, CR, DO, GT, HK, HN, ID, IL, IN, KP, MY, NI, NZ, PA, PE, PH, PY, SG, SV, TH, TR, TW, UY, VE, ZA);",
"     </li>",
"     <li>",
"      Patanol S (CO, CR, DO, GT, HN, NI, PA, SV, UY)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F9502941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Selective histamine H",
"     <sub>",
"      1",
"     </sub>",
"     -antagonist; inhibits release of histamine from mast cells. Inhibits histamine induced effects on conjunctival epithelial cells.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F9502943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Absorption: Low systemic absorption",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Protein binding: ~55% (primarily albumin)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Metabolism: Not extensively metabolized",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Half-life elimination: ~3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Excretion: Urine (60% to 70%, mostly as unchanged drug); feces (17%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9894 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.117.136.88-C2C11C53A9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20147=[""].join("\n");
var outline_f19_43_20147=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502830\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502831\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502836\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502960\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502959\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502961\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504109\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502833\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9503432\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502885\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502742\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502893\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502889\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502890\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299786\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502897\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502886\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502887\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502888\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504111\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10961997\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502941\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9502943\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9894\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9894|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32404?source=related_link\">",
"      Olopatadine (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?34/60/35779?source=related_link\">",
"      Olopatadine (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?8/2/8228?source=related_link\">",
"      Olopatadine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_43_20148="Floxuridine: Patient drug information";
var content_f19_43_20148=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Floxuridine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/21/39253?source=see_link\">",
"     see \"Floxuridine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F171607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      FUDR&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700666",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause unsafe effects. You will be closely watched when starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021107\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702129",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to floxuridine, fluorouracil, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021111\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697732",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug and for 1 month after stopping this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697946",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in color of skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into the liver.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12465 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-285D26EE14-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20148=[""].join("\n");
var outline_f19_43_20148=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F171607\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021105\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021107\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021106\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021111\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021112\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021114\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021109\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021116\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?38/21/39253?source=related_link\">",
"      Floxuridine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_43_20149="Dexchlorpheniramine: Drug information";
var content_f19_43_20149=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Dexchlorpheniramine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?30/59/31668?source=see_link\">",
"    see \"Dexchlorpheniramine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F158267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Alkylamine Derivative;",
"     </li>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist",
"     </li>",
"     <li>",
"      Histamine H",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist, First Generation",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F158240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Allergy symptoms: Oral: 2 mg every 4-6 hours or 4-6 mg timed release at bedtime or every 8-10 hours",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F158254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Allergy symptoms: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     2-5 years: 0.5 mg every 4-6 hours (do not use timed release)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     6-11 years: 1 mg every 4-6 hours or 4 mg timed release at bedtime",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F158241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15796024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15796025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F158222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Syrup, oral, as maleate: 2 mg/5 mL (473 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F158208\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F9496966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F158224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Perennial and seasonal allergic rhinitis and other allergic symptoms including urticaria",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9955430\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F158265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Slight to moderate drowsiness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Thickening of bronchial secretions",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache, fatigue, nervousness, dizziness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Appetite increase, weight gain, nausea, diarrhea, abdominal pain, dry mouth",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Pharyngitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Bronchospasm, epistaxis, hepatitis, palpitation",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F158227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to dexchlorpheniramine or any component of the formulation; narrow-angle glaucoma",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F158212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease (including hypertension and ischemic heart disease).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Increased intraocular pressure: Use with caution in patients with increased intraocular pressure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/urinary obstruction: Use with caution in patients with prostatic hyperplasia and/or GU obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pyloroduodenal obstruction: Use with caution in patients with pyloroduodenal obstruction (including stenotic peptic ulcer).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thyroid dysfunction: Use with caution in patients with thyroid dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedatives: Effects may be potentiated when used with other sedative drugs or ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid use of this potent anticholinergic agent due to increased risk of confusion, dry mouth, constipation, and other anticholinergic effects; clearance decreases in patients of advanced age (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Antihistamines may cause excitation in young children.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F158217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F158235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14386438\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Maternal antihistamine use has generally not resulted in an increased risk of birth defects; however, information specific to dexchlorpheniramine is limited.  Dexchlorpheniramine is the",
"     <i>",
"      dextro",
"     </i>",
"     -isomer of chlorpheniramine; also refer to the chlorpheniramine monograph. Antihistamines are recommended for the treatment of rhinitis, urticaria, and pruritus with rash in pregnant women (although second generation antihistamines may be preferred). Antihistamines are not recommended for treatment of pruritus associated with intrahepatic cholestasis in pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F158243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/contraindicated",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14386439\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Premature infants and newborns have a higher risk of intolerance to antihistamines. Use while breast-feeding is contraindicated by the manufacturer. Antihistamines may decrease maternal serum prolactin concentrations when administered prior to the establishment of nursing.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F158228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to meals.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F2524489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Syrup",
"     </b>",
"     (Dexchlorpheniramine Maleate Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 mg/5 mL (473 mL): $83.08",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Afeme (AR);",
"     </li>",
"     <li>",
"      Cortiflam-D (IN);",
"     </li>",
"     <li>",
"      Dapriton (HK);",
"     </li>",
"     <li>",
"      Delamin (TW);",
"     </li>",
"     <li>",
"      Destramin (BG);",
"     </li>",
"     <li>",
"      Dex Antihist (HK);",
"     </li>",
"     <li>",
"      Dexatamin (MY, SG);",
"     </li>",
"     <li>",
"      Dexferin (TW);",
"     </li>",
"     <li>",
"      Histaklor (ID);",
"     </li>",
"     <li>",
"      Isomerine (AR);",
"     </li>",
"     <li>",
"      Isomerine Repetabs (PY);",
"     </li>",
"     <li>",
"      Liramin (VE);",
"     </li>",
"     <li>",
"      Polaramin (AT, DK, IT, NO, SE);",
"     </li>",
"     <li>",
"      Polaramin Prolong Depottab (NO);",
"     </li>",
"     <li>",
"      Polaramin Prolongatum (SE);",
"     </li>",
"     <li>",
"      Polaramine (BB, BE, BF, BJ, BM, BR, BS, BZ, CH, CI, CO, ES, ET, FR, GH, GM, GN, GY, HK, ID, JM, KE, LR, LU, MA, ML, MR, MU, MW, MX, MY, NE, NG, NL, PR, SC, SD, SG, SL, SN, SR, TN, TT, TW, TZ, UG, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Polaramine (non-prescription) (AU);",
"     </li>",
"     <li>",
"      Polaramine Repetabs (FR, GR);",
"     </li>",
"     <li>",
"      Polarax (SG);",
"     </li>",
"     <li>",
"      Rhiniramine SR (HK);",
"     </li>",
"     <li>",
"      Somin (TW);",
"     </li>",
"     <li>",
"      Trenelone (PT)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F158211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Competes with histamine for H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract. Dexchlorpheniramine is the predominant active isomer of chlorpheniramine and is approximately twice as active as the racemic compound.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F158226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic (Simons, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 20-30 hours (Moreno, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: ~3 hours (Moreno, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/43/20149/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moreno RA, Oliveira-Silva D, Sverdloff CE, et al, \"Determination of Chlorpheniramine in Human Plasma by HPLC-ESI-MS/MS: Application to a Dexchlorpheniramine Comparative Bioavailability Study,\"",
"      <i>",
"       Biomed Chromatogr",
"      </i>",
"      , 2010, 24(7):774-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/43/20149/abstract-text/19924675/pubmed\" id=\"19924675\" target=\"_blank\">",
"        19924675",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Simons FE, \"Advances in H",
"      <sub>",
"       1",
"      </sub>",
"      -Antihistamines,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2004, 351(21):2203-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?19/43/20149/abstract-text/15548781/pubmed\" id=\"15548781\" target=\"_blank\">",
"        15548781",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9336 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-043A92644E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20149=[""].join("\n");
var outline_f19_43_20149=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158267\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158240\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158254\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158241\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15796024\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15796025\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158222\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158208\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9496966\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158224\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9955430\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158265\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158227\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158212\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299151\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158217\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158235\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14386438\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158243\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14386439\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158228\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2524489\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539843\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158211\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158226\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9336\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9336|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?30/59/31668?source=related_link\">",
"      Dexchlorpheniramine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_43_20150="Venlafaxine: Patient drug information";
var content_f19_43_20150=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Venlafaxine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     see \"Venlafaxine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/18/19752?source=see_link\">",
"     see \"Venlafaxine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F233762\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Effexor XR&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F233763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      CO Venlafaxine XR;",
"     </li>",
"     <li>",
"      Effexor XR&reg;;",
"     </li>",
"     <li>",
"      GD-Venlafaxine XR;",
"     </li>",
"     <li>",
"      Mylan-Venlafaxine XR;",
"     </li>",
"     <li>",
"      PMS-Venlafaxine XR;",
"     </li>",
"     <li>",
"      Ran-Venlafaxine XR;",
"     </li>",
"     <li>",
"      ratio-Venlafaxine XR;",
"     </li>",
"     <li>",
"      Riva-Venlafaxine XR;",
"     </li>",
"     <li>",
"      Sandoz-Venlafaxine XR;",
"     </li>",
"     <li>",
"      Teva-Venlafaxine XR;",
"     </li>",
"     <li>",
"      Venlafaxine XR",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020380\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Children and teens who take this drug may be at a greater risk of having thoughts or actions of suicide. Adults may also be at risk. The risk may be greater in people who have had these thoughts or actions in the past. Watch people who take this drug closely. Call the doctor right away if signs like low mood (depression), nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020382\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691808",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691728",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat anxiety.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692084",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat social anxiety problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692010",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat panic attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691994",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat obsessive-compulsive problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692021",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat post-traumatic stress.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hot flashes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691590",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease long-term pain problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3437665",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help diabetic nerve pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020381\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703125",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to venlafaxine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4232023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking any of these drugs: Linezolid or methylene blue.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020386\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for many weeks, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698504",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your eye pressure checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020387\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sweating a lot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020389\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are planning to harm yourself or the want to harm yourself gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Agitation, twitching, sweating, or muscle stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020384\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-acting products: Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may sprinkle contents of long-acting product on spoonful of applesauce. Do not chew.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020385\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020390\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020391\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11141 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-812927D4EA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20150=[""].join("\n");
var outline_f19_43_20150=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233762\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F233763\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020380\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020382\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020381\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020386\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020387\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020389\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020384\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020385\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020390\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020391\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=related_link\">",
"      Venlafaxine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/18/19752?source=related_link\">",
"      Venlafaxine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_43_20151="Degree of public health significance of iodine nutrition";
var content_f19_43_20151=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F79246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F79246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 636px\">",
"   <div class=\"ttl\">",
"    Degree of public health significance of iodine nutrition based on median urinary iodine: 1993 to 2006",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 616px; height: 450px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: World Health Organization. A Review of Nutrition Policies, 2010. Available at:",
"     <a href=\"file://www.who.int/nutrition/EB128_18_Backgroundpaper1_A_review_of_nutritionpolicies.pdf\" target=\"_blank\">",
"      file://www.who.int/nutrition/EB128_18_Backgroundpaper1_A_review_of_nutritionpolicies.pdf",
"     </a>",
"     (Accessed June 22, 2011).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20151=[""].join("\n");
var outline_f19_43_20151=null;
var title_f19_43_20152="Skin lesions in the returning traveler";
var content_f19_43_20152=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Skin lesions in the returning traveler",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/43/20152/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/43/20152/contributors\">",
"     Mary Elizabeth Wilson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/43/20152/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/43/20152/contributors\">",
"     Karin Leder, MBBS, FRACP, PhD, MPH, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/43/20152/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/43/20152/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/43/20152/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skin lesions are a common reason for returned travelers to seek medical evaluation. Among more than 17,000 ill returned travelers evaluated at one of the 30 GeoSentinel travel clinics worldwide, dermatologic disorders were the third most common problem (after systemic febrile illness and acute diarrhea) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/1\">",
"     1",
"    </a>",
"    ]. In another study of GeoSentinel network data including more than 25,000 patients evaluated following travel, a skin related diagnosis was reported in 18 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The causes, manifestations, and diagnosis of skin lesions in the returned traveler will be reviewed here [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES OF SKIN LESIONS IN TRAVELERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis for skin lesions that occur during or after travel is broad and includes infections due to pathogenic organisms (viruses, bacteria, fungi, helminths, protozoa), arthropod bites and infestations, allergic and hypersensitivity reactions [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/4\">",
"     4",
"    </a>",
"    ], injury by chemicals and ultraviolet light, and trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Among 269 patients in France with travel-associated skin problems, the most common diagnoses were [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cutaneous larva migrans &mdash; 25 percent",
"     </li>",
"     <li>",
"      Pyoderma &mdash; 18 percent",
"     </li>",
"     <li>",
"      Arthropod-reactive dermatitis &mdash;10 percent",
"     </li>",
"     <li>",
"      Myiasis &mdash; 9 percent",
"     </li>",
"     <li>",
"      Tungiasis &mdash; 6 percent",
"     </li>",
"     <li>",
"      Urticaria &mdash; 5 percent",
"     </li>",
"     <li>",
"      Fever and rash &mdash; 4 percent",
"     </li>",
"     <li>",
"      Cutaneous leishmaniasis &mdash; 3 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among 4594 returned travelers seen through the GeoSentinel network, the most common dermatologic disorders included cutaneous larva migrans (9.8 percent), insect bites (8.2 percent), skin abscess (7.7 percent), superinfected insect bites (6.8 percent), and allergic rash (5.5 percent). Dengue fever was diagnosed in 3.4 percent and leishmaniasis in 3.3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many skin lesions associated with exotic travel have cosmopolitan causes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/8\">",
"     8",
"    </a>",
"    ]. Additional skin problems related to travel to tropical and developing areas include sunburn, scabies, staphylococcal and streptococcal infections, and prickly heat. Chronic skin problems such as acne and atopic dermatitis may worsen in a tropical environment. Exposure to tropical plants or plant products may cause immediate or delayed hypersensitivity reactions or phytophotodermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/9\">",
"     9",
"    </a>",
"    ]. Hypersensitivity reactions to drugs taken for treatment or prophylaxis may occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     History and exposures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Key elements of the history to help define possible diagnoses include: time since travel, location and duration of travel, and exposure history (eg, fresh or sea water, animals, arthropods, plants, breaks in skin including tattoos, sexual activity, occupational activities, and medications including over the counter drugs). The time of onset of skin lesion(s) and their evolution, associated symptoms (eg, itching or pain), and accompanying systemic symptoms are also useful data in the evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SKIN LESIONS AND SYSTEMIC INFECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dermatologic manifestations may offer a valuable clue for diagnosis of systemic illness. Several systemic infections are associated with skin lesions (",
"    <a class=\"graphic graphic_table graphicRef50792 \" href=\"UTD.htm?43/19/44347\">",
"     table 1",
"    </a>",
"    ). The initial focus should be on infections that are treatable, transmissible, or associated with serious sequelae or death. In a prospective study of 62 returned travelers to France with fever and widespread rash, the most common diagnoses were chikungunya (35 percent), dengue (26 percent), and African tick bite fever (10 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/10\">",
"     10",
"    </a>",
"    ]. The high rate of chikungunya infection reflected frequent travel to the Indian Ocean region, where there was an ongoing epidemic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8401513\">",
"    <span class=\"h2\">",
"     Dengue and other viral infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diffuse maculopapular rash is observed in 30 to 50 percent of patients with dengue fever. Diffuse erythema resembling a sunburn or toxic shock syndrome may be present early in the course of infection. The rash of dengue may become petechial or hemorrhagic. Intense itching may be observed toward the end of the febrile period [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/11\">",
"     11",
"    </a>",
"    ]. (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18985?source=see_link\">",
"     \"Clinical presentation and diagnosis of dengue virus infections\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Measles and rubella occasionally occur in travelers who have visited areas where these viruses circulate. A diffuse rash is also present in 40 to 50 percent of patients with chikungunya, an infection characterized by intense polyarthralgias, arthritis, and tenosynovitis, findings not typical of dengue [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15576?source=see_link\">",
"     \"Chikungunya fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Rickettsial infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rickettsial infections occur worldwide and are a relatively common, treatable cause of fever and rash in travelers [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. Skin findings vary with the type of rickettsial infection and range from diffuse lesions to a single eschar. The appearance of rash due to rickettsial infection may be delayed or absent. The most characteristic rashes for many of the spotted fever rickettsioses are macular, maculopapular, and petechial rashes. Vesicular eruptions resembling varicella have been reported in infections due to Rickettsia conorii, R. akari, and R. australis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. A diffuse rash is observed in 30 to 60 percent of patients with scrub typhus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/51/14135?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Rocky Mountain spotted fever\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/6/18534?source=see_link\">",
"     \"Scrub typhus: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27796?source=see_link\">",
"     \"The epidemiology and clinical manifestations of murine typhus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29220?source=see_link\">",
"     \"Rickettsialpox\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rash is common among travelers with African tick bite fever (ATBF) due to Rickettsia africae. Among 940 Norwegian travelers to rural sub-Equatorial Africa, 4 percent had serologic evidence of infection with R. africae. Of these, among the 38 travelers with flu-like symptoms, 26 percent were diagnosed with ATBF [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/17\">",
"     17",
"    </a>",
"    ]. In another series including 119 cases of ATBF, rash occurred in 46 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/21\">",
"     21",
"    </a>",
"    ]. Rashes were most often maculopapular (51 percent); vesicular rashes and purpuric changes were also observed (45 and 4 percent, respectively). An eschar at the site of the tick attachment was noted in 95 percent of patients; multiple eschars were observed in 54 percent of cases. Eschars most commonly occurred on the legs (62 percent), followed by chest, abdomen, or groin (18 percent), arms (11 percent), face, neck, or scalp (5 percent), and back or buttocks (4 percent). Regional lymphadenopathy was observed in 43 percent of patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28808?source=see_link\">",
"     \"Other spotted fever group rickettsial infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     African trypanosomiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;African trypanosomiasis (sleeping sickness) is rare in travelers, though an increase in cases has been observed in some areas, including among short-term travelers to Tanzania [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Early recognition is important since therapy is more complex once central nervous system (CNS) invasion has occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. A chancre (indurated nodule) appears at the site of the tsetse fly bite in up to 70 to 90 percent of infected patients. A rash characterized by circinate erythematous patches, most prominent on the trunk, may appear later [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Fungal infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coccidioidomycosis is associated with rash. Among 20 patients with acute symptomatic coccidioidomycosis related to inhalation exposures in Mexico, 62 percent developed a rash [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/27\">",
"     27",
"    </a>",
"    ]. In most patients the manifestations were papular lesions progressing to maculopapular lesions on the trunk and sometimes on palms, soles, and buccal mucosa. Fever, headache, and chest pain were also prominent findings [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other fungal infections can cause localized findings at the site of skin penetration. (See",
"    <a class=\"local\" href=\"#H7117413\">",
"     'Nodules'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Sexually-transmitted infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexual contact with new partners is common during travel. Several STDs can cause systemic infection and nongenital skin lesions, including syphilis, gonorrhea, and acute HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/28\">",
"     28",
"    </a>",
"    ]. In one study, 3 percent of returned travelers with fever and widespread rash had acute HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7117204\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Diffuse skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct penetration of the skin by pathogens may result in diffuse skin lesions. This frequently occurs following immersion in water during recreational or occupational activities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Swimmer's itch",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cercarial dermatitis, also known as swimmer's itch, is an itchy maculopapular rash that follows skin penetration by cercariae of nonhuman schistosomes (often avian) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. The distribution of the rash is limited to areas of the body immersed in water. Itchy red papules that may become vesicular develop hours to a day or so after exposure to water contaminated with schistosomes. This infection usually arises from exposure to fresh water, but occasionally contact with brackish or salt water can lead to the rash. The nonhuman schistosomes are unable to complete development in the human host though elicit an intense inflammatory response that is more rapid and severe if repeat exposure occurs. Nonhuman schistosomes are widely distributed and found on all continents.",
"   </p>",
"   <p>",
"    Human schistosomes can also produce a rash (redness, urticaria, itchy papules) after penetration of the skin. Among 28 travelers to Mali, Africa who developed schistosomiasis after water exposure, 10 (36 percent) had schistosomal dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/38/15977?source=see_link\">",
"     \"Epidemiology, pathogenesis, and clinical features of schistosomiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Seabather's eruption",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seabather's eruption is due to skin penetration by Linuche unguiculata, Edwardsiella lineata, and probably other larvae of the phylum Cnidaria, which are found in oceans (salt water) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. The tiny jellyfish larvae release nematocysts and inject toxin. The distribution of the lesions matches areas covered by a bathing suit, wet suit, or points of pressure (eg, wristbands of diving suits, flexural areas). Skin lesions are inflammatory papules, often becoming vesicular or pustular. Many descriptions have been reported from the Atlantic coast of North America and from the Caribbean.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Hot tub folliculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diffuse folliculitis (\"hot tub folliculitis\") is usually caused by Pseudomonas aeruginosa that contaminates swimming pools, hot tubs, whirlpools, or water slides. An itchy, maculopapular and vesiculopustular eruption develops within 48 hours of exposure and is most common in areas covered by bathing garments (",
"    <a class=\"graphic graphic_picture graphicRef65119 \" href=\"UTD.htm?33/14/34031\">",
"     picture 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29098?source=see_link&amp;anchor=H8#H8\">",
"     \"Fever and rash in the immunocompetent patient\", section on 'Exposure history'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/8/43142?source=see_link&amp;anchor=H9#H9\">",
"     \"Pseudomonas aeruginosa skin, soft tissue, and bone infections\", section on 'Folliculitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7117413\">",
"    <span class=\"h2\">",
"     Nodules",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nodules in the skin can occur as a result of a variety of parasitic infections (",
"    <a class=\"graphic graphic_table graphicRef74491 \" href=\"UTD.htm?13/51/14140\">",
"     table 2",
"    </a>",
"    ). Nodular lesions are found in echinococcosis, dirofilariasis, cysticercosis, and toxocariasis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/35-38\">",
"     35-38",
"    </a>",
"    ]. Cutaneous leishmaniasis lesions can be nodular initially. Following treatment for visceral leishmaniasis, a diffuse nodular eruption can develop (post kala-azar dermal leishmaniasis). Onchocerciasis is a common cause of nodules among residents of endemic areas, but typically causes an itchy rash among travelers who become infected [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. Papular lesions can occur in the setting of schistosomiasis, due to ectopic deposition of schistosome eggs years after exposure to schistosomiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fungal infections can also cause nodular skin lesions. P. marneffei has become an important cause of infection in AIDS patients, especially in Southeast Asia. Several bacterial pathogens, including mycobacteria, Nocardia, and Bartonella, can also cause nodular skin lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7117851\">",
"    <span class=\"h2\">",
"     Lymphangitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphangitis may be caused by a variety of pathogens including Nocardia, tularemia, Mycobacterium marinum, Leishmania brasiliensis, and sporotrichosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/44\">",
"     44",
"    </a>",
"    ]. Many of these pathogens have a cosmopolitan distribution, and travel is not necessary to acquire infection except in the case of leishmaniasis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11942?source=see_link&amp;anchor=H5#H5\">",
"     \"Lymphangitis\", section on 'Nodular lymphangitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30888?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and treatment of tularemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=see_link\">",
"     \"Clinical features and diagnosis of sporotrichosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lymphangitis with retrograde progression, lymphadenitis, orchitis, and epididymitis are characteristic of bancroftian filariasis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Brugia malayi, B. timori, and other filarial parasites cause similar clinical findings. Infections with these filarial parasites are rare in short-term travelers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7117858\">",
"    <span class=\"h2\">",
"     Ulcers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of skin ulcers include pyoderma, tularemia, mycobacterial infection, anthrax, and others (",
"    <a class=\"graphic graphic_table graphicRef56355 \" href=\"UTD.htm?38/62/39916\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. Several of these pathogens initially induce nodules that progress to ulceration, usually at the site of inoculation of the organism. Cutaneous leishmaniasis typically begins as a papule that enlarges to a nodule with a central crust that drops off to expose an ulcer that is painless, chronic, and may have a raised border. Several sexually transmitted pathogens (such as chancroid) also cause ulcers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7118242\">",
"    <span class=\"h2\">",
"     Hemorrhagic lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Illnesses associated with petechial rashes and hemorrhage require urgent evaluation. Causes include viral hemorrhagic fevers, dengue fever, leptospirosis, meningococcemia, and rickettsial infections (",
"    <a class=\"graphic graphic_table graphicRef70779 \" href=\"UTD.htm?0/49/795\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Outbreaks of leptospirosis have occurred in travelers [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/50\">",
"     50",
"    </a>",
"    ]; manifestations can be protean and have been mistaken for dengue hemorrhagic and other viral hemorrhagic fevers [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Leptospirosis can also be associated with an erythema nodosum-like rash [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/31/4597?source=see_link\">",
"     \"Treatment and prevention of leptospirosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Migratory lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several parasites migrate in human tissues (",
"    <a class=\"graphic graphic_table graphicRef71472 \" href=\"UTD.htm?11/10/11436\">",
"     table 5",
"    </a>",
"    ). Migrating parasites frequently cause eosinophilia. These have a restricted geographic distribution, so knowledge of travel and exposures is important in establishing the differential diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Cutaneous larva migrans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cutaneous larva migrans is the most common migratory skin infection in travelers [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/1,54-56\">",
"     1,54-56",
"    </a>",
"    ]. It develops when infective larvae of animal hookworms (usually Ancylostoma braziliense) penetrate the skin and migrate in superficial tissues, producing a characteristic serpiginous eruption (",
"    <a class=\"graphic graphic_picture graphicRef79025 \" href=\"UTD.htm?29/56/30594\">",
"     picture 2",
"    </a>",
"    ). Humans become infected after direct contact with soil, sand, or other material contaminated with feces from hookworm infected animals, usually dogs or cats.",
"   </p>",
"   <p>",
"    Lesions appear within several days of exposure and most often are found on the feet, buttocks, and thighs [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/57\">",
"     57",
"    </a>",
"    ]. Lesions can be itchy or painful and may be papular or vesiculobullous. The lesions can be complicated by secondary staphylococcal or streptococcal infection. Cutaneous larva migrans is typically self-limited, though treatment can shorten the clinical course [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/58\">",
"     58",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36229?source=see_link\">",
"     \"Cutaneous larva migrans (creeping eruption)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Strongyloidiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic strongyloidiasis can be associated with episodic, itchy, urticarial, or serpiginous skin lesions (larva currens). These lesions are most often located on the buttocks, groin, or trunk [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/59,60\">",
"     59,60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Gnathostomiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Migrating Gnathostoma larvae cause localized swellings that typically last one to two weeks and are associated with edema, pain, itching, and erythema [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. Lesions begin three to four weeks after ingestion of the parasite, although the swelling can continue to appear months to years later. One or multiple parasites may be present and can migrate to tissues throughout the body including the CNS, gastrointestinal or genitourinary tracts, lungs, and eye [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Loiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Loiasis is characterized by localized areas of angioedema known as Calabar swellings. These are warm, itchy, or painful swellings that may come and go, often recurring multiple times per year [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/64-66\">",
"     64-66",
"    </a>",
"    ]. Worms can survive for more than 10 years and can occasionally be observed crossing the conjunctiva.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Arthropod bites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arthropod bites induce skin reactions in one of three ways (",
"    <a class=\"graphic graphic_table graphicRef69989 \" href=\"UTD.htm?33/10/33964\">",
"     table 6",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Transmission of a pathogen [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/67\">",
"       67",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Localized and systemic hypersensitivity reaction [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/68\">",
"       68",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Retained arthropod parts, which can cause a localized granulomatous reaction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A few arthropods inhabit human tissues or infest hair and superficial layers of skin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8401226\">",
"    <span class=\"h3\">",
"     Myiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common presentation of myiasis in returning travelers is furuncular myiasis caused by Dermatobia hominis, the botfly (",
"    <a class=\"graphic graphic_picture graphicRef62332 \" href=\"UTD.htm?0/19/305\">",
"     picture 3",
"    </a>",
"    ), and Cordylobia anthropophaga, the tumbu fly [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. In each instance, larvae penetrate skin and develop in subdermal tissue. Typically one larva is found in each lesion, though multiple lesions may be present, especially with the tumbu fly.",
"   </p>",
"   <p>",
"    Patients typically note an apparent insect bite that slowly enlarges over time to a nodule measuring 1 to 3 cm in diameter. Scant serosanguineous fluid may drain from the lesion. Patients may have a sensation of irritation, crawling, or episodic lancinating pain.",
"   </p>",
"   <p>",
"    Removal of the intact larva is curative, although secondary bacterial infection can complicate the infestation. A range of approaches have been successful including occluding the opening (eg, with petroleum jelly or strips of bacon) and gentle extraction of the intact larva when it protrudes its abdomen to reach air (",
"    <a class=\"graphic graphic_picture graphicRef54606 \" href=\"UTD.htm?27/41/28311\">",
"     picture 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/70,71\">",
"     70,71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8401410\">",
"    <span class=\"h3\">",
"     Tungiasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The female sand flea (Tunga penetrans) can penetrate human skin, usually on the feet and often under toenails and between toes. The flea feeds on blood and enlarges to a spherical form 5 to 8 mm in diameter and produces eggs that are expelled through the host's skin [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20152/abstract/72\">",
"     72",
"    </a>",
"    ]. The flea can live in tissues for up to a month and causes itching and pain. Lesions are nodular, may be single or multiple, and sometimes ulcerate. The treatment is removal of the flea.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8402106\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Skin lesions are a common reason for returned travelers to seek medical evaluation. The differential diagnosis for skin lesions that occur during or after travel is broad and includes infectious and noninfectious causes. The most common causes include cutaneous larva migrans, insect bites, skin abscess, allergic rash, dengue fever, and leishmaniasis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Causes of skin lesions in travelers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several systemic infections are associated with skin lesions (",
"      <a class=\"graphic graphic_table graphicRef50792 \" href=\"UTD.htm?43/19/44347\">",
"       table 1",
"      </a>",
"      ). The most common include chikungunya, dengue, and African tick bite fever. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Skin lesions and systemic infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Direct penetration of the skin by pathogens may result in diffuse skin lesions. This frequently occurs following immersion in water during recreational or occupational activities. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diffuse skin lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nodules in the skin can occur as a result of a variety of parasitic infections (",
"      <a class=\"graphic graphic_table graphicRef74491 \" href=\"UTD.htm?13/51/14140\">",
"       table 2",
"      </a>",
"      ). Fungal infections can also cause nodular skin lesions. Several bacterial pathogens, including mycobacteria, Nocardia, and Bartonella, can also cause nodular skin lesions. Lymphangitis may be caused by a variety of pathogens including Nocardia, tularemia, Mycobacterium marinum, Leishmania brasiliensis, and sporotrichosis. (See",
"      <a class=\"local\" href=\"#H7117413\">",
"       'Nodules'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7117851\">",
"       'Lymphangitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A range of pathogens can cause skin ulcers (",
"      <a class=\"graphic graphic_table graphicRef56355 \" href=\"UTD.htm?38/62/39916\">",
"       table 3",
"      </a>",
"      ). Several of these pathogens initially induce nodules that progress to ulceration, usually at the site of inoculation of the organism. Several sexually transmitted pathogens (such as chancroid) also cause ulcers. (See",
"      <a class=\"local\" href=\"#H7117858\">",
"       'Ulcers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Illnesses associated with petechial rash and hemorrhage require urgent evaluation. Causes include viral hemorrhagic fevers, dengue fever, leptospirosis, meningococcemia, and rickettsial infections (",
"      <a class=\"graphic graphic_table graphicRef70779 \" href=\"UTD.htm?0/49/795\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7118242\">",
"       'Hemorrhagic lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Causes of migratory lesions include cutaneous larva migrans, strongyloidiasis, gnathostomiasis, and loiasis (",
"      <a class=\"graphic graphic_table graphicRef71472 \" href=\"UTD.htm?11/10/11436\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Migratory lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Skin lesions due to arthropod bites include myiasis and tungiasis (",
"      <a class=\"graphic graphic_table graphicRef69989 \" href=\"UTD.htm?33/10/33964\">",
"       table 6",
"      </a>",
"      ) (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Arthropod bites'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/1\">",
"      Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/2\">",
"      Lederman ER, Weld LH, Elyazar IR, et al. Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network. Int J Infect Dis 2008; 12:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/3\">",
"      Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med 2002; 347:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/4\">",
"      Dromgoole SH, Maibach HI. Sunscreening agent intolerance: contact and photocontact sensitization and contact urticaria. J Am Acad Dermatol 1990; 22:1068.",
"     </a>",
"    </li>",
"    <li>",
"     Wilson, ME. A world guide to infections: Diseases, distribution, diagnosis. Oxford University Press, New York 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/6\">",
"      Wilson ME. Skin problems in the traveler. Infect Dis Clin North Am 1998; 12:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/7\">",
"      Caumes E, Carri&egrave;re J, Guermonprez G, et al. Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. Clin Infect Dis 1995; 20:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/8\">",
"      Lucchina LC, Wilson ME, Drake LA. Dermatology and the recently returned traveler: infectious diseases with dermatologic manifestations. Int J Dermatol 1997; 36:167.",
"     </a>",
"    </li>",
"    <li>",
"     Larson, JL, Clark, RF. Plant toxins in the tropics, In: Tropical Infectious Diseases: Principles, Pathogens, and Practice, Guerrant, RL, Walker, DH, Weller, PF (Eds), Churchill Livingstone, Philadelphia 1999. p.155.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/10\">",
"      Hochedez P, Canestri A, Guihot A, et al. Management of travelers with fever and exanthema, notably dengue and chikungunya infections. Am J Trop Med Hyg 2008; 78:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/11\">",
"      Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med 2005; 353:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/12\">",
"      Taubitz W, Cramer JP, Kapaun A, et al. Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis 2007; 45:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/13\">",
"      Borgherini G, Poubeau P, Staikowsky F, et al. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007; 44:1401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/14\">",
"      Marschang A, Nothdurft HD, Kumlien S, von Sonnenburg F. Imported rickettsioses in German travelers. Infection 1995; 23:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/15\">",
"      Walker DH. Rickettsioses of the spotted fever group around the world. J Dermatol 1989; 16:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/16\">",
"      Walker DH, Dumler JS. Emerging and reemerging rickettsial diseases. N Engl J Med 1994; 331:1651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/17\">",
"      Jensenius M, Fournier PE, Vene S, et al. African tick bite fever in travelers to rural sub-Equatorial Africa. Clin Infect Dis 2003; 36:1411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/18\">",
"      Kemper CA, Spivack AP, Deresinski SC. Atypical papulovesicular rash due to infection with Rickettsia conorii. Clin Infect Dis 1992; 15:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/19\">",
"      Kass EM, Szaniawski WK, Levy H, et al. Rickettsialpox in a New York City hospital, 1980 to 1989. N Engl J Med 1994; 331:1612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/20\">",
"      Hudson BJ, McPetrie R, Kitchener-Smith J, Eccles J. Vesicular rash associated with infection due to Rickettsia australis. Clin Infect Dis 1994; 18:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/21\">",
"      Raoult D, Fournier PE, Fenollar F, et al. Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa. N Engl J Med 2001; 344:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/22\">",
"      Ripamonti D, Massari M, Arici C, et al. African sleeping sickness in tourists returning from Tanzania: the first 2 Italian cases from a small outbreak among European travelers. Clin Infect Dis 2002; 34:E18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/23\">",
"      Jelinek T, Bisoffi Z, Bonazzi L, et al. Cluster of African trypanosomiasis in travelers to Tanzanian national parks. Emerg Infect Dis 2002; 8:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/24\">",
"      Iborra C, Danis M, Bricaire F, Caumes E. A traveler returning from Central Africa with fever and a skin lesion. Clin Infect Dis 1999; 28:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/25\">",
"      McGovern TW, Williams W, Fitzpatrick JE, et al. Cutaneous manifestations of African trypanosomiasis. Arch Dermatol 1995; 131:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/26\">",
"      Cochran R, Rosen T. African trypanosomiasis in the United States. Arch Dermatol 1983; 119:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/27\">",
"      Cairns L, Blythe D, Kao A, et al. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis 2000; 30:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/28\">",
"      Lapins J, Lindb&auml;ck S, Lidbrink P, et al. Mucocutaneous manifestations in 22 consecutive cases of primary HIV-1 infection. Br J Dermatol 1996; 134:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/29\">",
"      Hoeffler DF. Cercarial dermatitis. Arch Environ Health 1974; 29:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/30\">",
"      Centers for Disease Control (CDC). Cercarial dermatitis outbreak at a state park--Delaware, 1991. MMWR Morb Mortal Wkly Rep 1992; 41:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/31\">",
"      Visser LG, Polderman AM, Stuiver PC. Outbreak of schistosomiasis among travelers returning from Mali, West Africa. Clin Infect Dis 1995; 20:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/32\">",
"      Freudenthal AR, Joseph PR. Seabather's eruption. N Engl J Med 1993; 329:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/33\">",
"      Tomchik RS, Russell MT, Szmant AM, Black NA. Clinical perspectives on seabather's eruption, also known as 'sea lice'. JAMA 1993; 269:1669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/34\">",
"      Wong DE, Meinking TL, Rosen LB, et al. Seabather's eruption. Clinical, histologic, and immunologic features. J Am Acad Dermatol 1994; 30:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/35\">",
"      Bresson-Hadni S, Humbert P, Paintaud G, et al. Skin localization of alveolar echinococcosis of the liver. J Am Acad Dermatol 1996; 34:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/36\">",
"      Shenefelt PD, Esperanza L, Lynn A. Elusive migratory subcutaneous dirofilariasis. J Am Acad Dermatol 1996; 35:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/37\">",
"      Wortman PD. Subcutaneous cysticercosis. J Am Acad Dermatol 1991; 25:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/38\">",
"      Rook A, Staughton R. The cutaneous manifestations of toxocariasis. Dermatologica 1972; 144:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/39\">",
"      McCarthy JS, Ottesen EA, Nutman TB. Onchocerciasis in endemic and nonendemic populations: differences in clinical presentation and immunologic findings. J Infect Dis 1994; 170:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/40\">",
"      Pryce D, Behrens R, Davidson R, et al. Onchocerciasis in members of an expedition to Cameroon: role of advice before travel and long term follow up. BMJ 1992; 304:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/41\">",
"      Encarnacion CF, Giordano MF, Murray HW. Onchocerciasis in New York City. The Moa-Manhattan connection. Arch Intern Med 1994; 154:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/42\">",
"      Davis-Reed L, Theis JH. Cutaneous schistosomiasis: report of a case and review of the literature. J Am Acad Dermatol 2000; 42:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/43\">",
"      Matteelli A, Castelli F, Spinetti A, et al. Short report: verruga peruana in an Italian traveler from Peru. Am J Trop Med Hyg 1994; 50:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/44\">",
"      Kostman JR, DiNubile MJ. Nodular lymphangitis: a distinctive but often unrecognized syndrome. Ann Intern Med 1993; 118:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/45\">",
"      Davis BR. Filariases. Dermatol Clin 1989; 7:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/46\">",
"      WARTMAN WB. Filariasis in American armed forces in World War II. Medicine (Baltimore) 1947; 26:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/47\">",
"      van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K. Mycobacterium ulcerans infection. Lancet 1999; 354:1013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/48\">",
"      Evans ME, Gregory DW, Schaffner W, McGee ZA. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 1985; 64:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/49\">",
"      McGovern TW, Christopher GW, Eitzen EM. Cutaneous manifestations of biological warfare and related threat agents. Arch Dermatol 1999; 135:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/50\">",
"      Centers for Disease Control and Prevention (CDC). Outbreak of leptospirosis among white-water rafters--Costa Rica, 1996. MMWR Morb Mortal Wkly Rep 1997; 46:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/51\">",
"      Ko AI, Galv&atilde;o Reis M, Ribeiro Dourado CM, et al. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 1999; 354:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/52\">",
"      Monsuez JJ, Kidouche R, Le Gueno B, Postic D. Leptospirosis presenting as haemorrhagic fever in visitor to Africa. Lancet 1997; 349:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/53\">",
"      Derham RL, Owens GG, Wooldridge MA. Leptospirosis as a cause of erythema nodosum. Br Med J 1976; 2:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/54\">",
"      Davies HD, Sakuls P, Keystone JS. Creeping eruption. A review of clinical presentation and management of 60 cases presenting to a tropical disease unit. Arch Dermatol 1993; 129:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/55\">",
"      Jelinek T, Maiwald H, Nothdurft HD, L&ouml;scher T. Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients. Clin Infect Dis 1994; 19:1062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/56\">",
"      Tremblay A, MacLean JD, Gyorkos T, Macpherson DW. Outbreak of cutaneous larva migrans in a group of travellers. Trop Med Int Health 2000; 5:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/57\">",
"      Richey TK, Gentry RH, Fitzpatrick JE, Morgan AM. Persistent cutaneous larva migrans due to Ancylostoma species. South Med J 1996; 89:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/58\">",
"      Caumes E, Carriere J, Datry A, et al. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg 1993; 49:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/59\">",
"      ARTHUR RP, SHELLEY WB. Larva currens; a distinctive variant of cutaneous larva migrans due to Strongyloides stercoralis. AMA Arch Derm 1958; 78:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/60\">",
"      von Kuster LC, Genta RM. Cutaneous manifestations of strongyloidiasis. Arch Dermatol 1988; 124:1826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/61\">",
"      Rusnak JM, Lucey DR. Clinical gnathostomiasis: case report and review of the English-language literature. Clin Infect Dis 1993; 16:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/62\">",
"      Crowley JJ, Kim YH. Cutaneous gnathostomiasis. J Am Acad Dermatol 1995; 33:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/63\">",
"      Diaz Camacho SP, Zazueta Ramos M, Ponce Torrecillas E, et al. Clinical manifestations and immunodiagnosis of gnathostomiasis in Culiacan, Mexico. Am J Trop Med Hyg 1998; 59:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/64\">",
"      Nutman TB, Miller KD, Mulligan M, Ottesen EA. Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations. J Infect Dis 1986; 154:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/65\">",
"      Klion AD, Massougbodji A, Sadeler BC, et al. Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis 1991; 163:1318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/66\">",
"      Rakita RM, White AC Jr, Kielhofner MA. Loa loa infection as a cause of migratory angioedema: report of three cases from the Texas Medical Center. Clin Infect Dis 1993; 17:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/67\">",
"      Myers SA, Sexton DJ. Dermatologic manifestations of arthropod-borne diseases. Infect Dis Clin North Am 1994; 8:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/68\">",
"      Brown S, Becher J, Brady W. Treatment of ectoparasitic infections: review of the English-language literature, 1982-1992. Clin Infect Dis 1995; 20 Suppl 1:S104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/69\">",
"      Arosemena R, Booth SA, Su WP. Cutaneous myiasis. J Am Acad Dermatol 1993; 28:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/70\">",
"      Brewer TF, Wilson ME, Gonzalez E, Felsenstein D. Bacon therapy and furuncular myiasis. JAMA 1993; 270:2087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/71\">",
"      Boggild AK, Keystone JS, Kain KC. Furuncular myiasis: a simple and rapid method for extraction of intact Dermatobia hominis larvae. Clin Infect Dis 2002; 35:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20152/abstract/72\">",
"      Sanusi ID, Brown EB, Shepard TG, Grafton WD. Tungiasis: report of one case and review of the 14 reported cases in the United States. J Am Acad Dermatol 1989; 20:941.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3895 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.65.66-4367187BB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20152=[""].join("\n");
var outline_f19_43_20152=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8402106\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES OF SKIN LESIONS IN TRAVELERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      History and exposures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SKIN LESIONS AND SYSTEMIC INFECTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8401513\">",
"      Dengue and other viral infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Rickettsial infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      African trypanosomiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Fungal infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Sexually-transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7117204\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Diffuse skin lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Swimmer's itch",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Seabather's eruption",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Hot tub folliculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7117413\">",
"      Nodules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7117851\">",
"      Lymphangitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7117858\">",
"      Ulcers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7118242\">",
"      Hemorrhagic lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Migratory lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Cutaneous larva migrans",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Strongyloidiasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Gnathostomiasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Loiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Arthropod bites",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8401226\">",
"      - Myiasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8401410\">",
"      - Tungiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8402106\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3895\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3895|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/14/34031\" title=\"picture 1\">",
"      Hot tub folliculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/56/30594\" title=\"picture 2\">",
"      Ankle cutaneous larva migrans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/19/305\" title=\"picture 3\">",
"      Botfly larva",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/41/28311\" title=\"picture 4\">",
"      Botfly extraction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3895|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/19/44347\" title=\"table 1\">",
"      Systemic infections associated with skin lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/51/14140\" title=\"table 2\">",
"      Parasitic infections associated with nodular lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/62/39916\" title=\"table 3\">",
"      Skin ulcers in travelers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/49/795\" title=\"table 4\">",
"      Infections associated with hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/10/11436\" title=\"table 5\">",
"      Migratory skin lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/10/33964\" title=\"table 6\">",
"      Arthropod bite and infestations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15576?source=related_link\">",
"      Chikungunya fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/11/12469?source=related_link\">",
"      Clinical features and diagnosis of sporotrichosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/51/14135?source=related_link\">",
"      Clinical manifestations and diagnosis of Rocky Mountain spotted fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30888?source=related_link\">",
"      Clinical manifestations, diagnosis, and treatment of tularemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/34/18985?source=related_link\">",
"      Clinical presentation and diagnosis of dengue virus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36229?source=related_link\">",
"      Cutaneous larva migrans (creeping eruption)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/38/15977?source=related_link\">",
"      Epidemiology, pathogenesis, and clinical features of schistosomiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29098?source=related_link\">",
"      Fever and rash in the immunocompetent patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11942?source=related_link\">",
"      Lymphangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28808?source=related_link\">",
"      Other spotted fever group rickettsial infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/8/43142?source=related_link\">",
"      Pseudomonas aeruginosa skin, soft tissue, and bone infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29220?source=related_link\">",
"      Rickettsialpox",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/6/18534?source=related_link\">",
"      Scrub typhus: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27796?source=related_link\">",
"      The epidemiology and clinical manifestations of murine typhus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/31/4597?source=related_link\">",
"      Treatment and prevention of leptospirosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_43_20153="MDAS II";
var content_f19_43_20153=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F69509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F69509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 624px\">",
"   <div class=\"ttl\">",
"    Memorial Delirium Assessment Scale (MDAS) cont.",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 604px; height: 786px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Breitbart, W, Rosenfield, B, Roth, A, Smith, M, Cohen, K, Passik, S. The memorial delirium assessment scale. J Pain Symptom Manage 1997; 13:128. Copyright &copy;1997 The US Cancer Pain Relief Committee.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20153=[""].join("\n");
var outline_f19_43_20153=null;
var title_f19_43_20154="Approach to the HIV-infected patient with pulmonary symptoms";
var content_f19_43_20154=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the HIV-infected patient with pulmonary symptoms",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/43/20154/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/43/20154/contributors\">",
"     Diane E Stover, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/43/20154/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/43/20154/contributors\">",
"     John G Bartlett, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/43/20154/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?19/43/20154/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?19/43/20154/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?19/43/20154/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acquired immunodeficiency syndrome (AIDS) epidemic remains one of the most important global health problems of the 21st century [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the incidence of AIDS-related opportunistic infections (OIs) declined dramatically in the United States and Europe following the clinical development of potent antiretroviral therapy (ART). Despite these gains, pulmonary disease remains a significant cause of morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=see_link\">",
"     \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Just as the pulmonary disorders associated with HIV infection have changed in the 21st century, the approach to the diagnosis of pulmonary disease has evolved as well (",
"    <a class=\"graphic graphic_figure graphicRef78591 \" href=\"UTD.htm?38/39/39550\">",
"     figure 1",
"    </a>",
"    ). The clinical assessment of pulmonary symptoms in HIV-infected patients will be reviewed here; specific conditions and their management are discussed separately. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Pulmonary diseases and HIV",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spectrum of pulmonary disease in patients with HIV has changed over the past decades [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. Although Pneumocystis carinii (jirovecii) pneumonia (PCP) remains the most common AIDS-defining OI in the United States, its incidence has decreased with improved prophylactic and antiretroviral therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7577?source=see_link\">",
"     \"Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HIV-infected patients are at risk for a number of other pulmonary infections in addition to PCP. The data on the incidence of bacterial pneumonia in the HAART era are mixed [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15449?source=see_link\">",
"     \"Bacterial pulmonary infections in HIV-infected patients\"",
"    </a>",
"    .) However, bacterial pneumonia remains a common complication in HIV-infected patients and has increased as a proportion of diagnosed pulmonary infections despite an overall decrease in the number of cases, as illustrated by the following [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/10\">",
"     10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study evaluated 1898 HIV-infected patients with CD4 counts",
"      <span class=\"nowrap\">",
"       &lt;200/mm",
"       <sup>",
"        3",
"       </sup>",
"      </span>",
"      seen in an HIV clinic between 1993 and 1998 [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/10\">",
"       10",
"      </a>",
"      ]. Bacterial pneumonia decreased from the first half of 1993 to the second half of 1997 (22.7 versus 9.1 episodes per 100 person-years). Risk factors for the development of bacterial pneumonia included: lower CD4 counts, IDU, and prior PCP; inclusion of a protease inhibitor in the antiretroviral regimen decreased the risk of bacterial pneumonia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Millions of people are infected with both HIV and tuberculosis (TB), especially in developing countries. In Africa, TB is the most common pulmonary complication of HIV, and at least one-third of all cases occur in HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/11\">",
"     11",
"    </a>",
"    ]. In the United States, HIV-associated TB is most common among IDUs [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/12\">",
"     12",
"    </a>",
"    ]. In addition, infection caused by endemic fungi and parasites contributes substantially to the morbidity and mortality of this population worldwide. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=see_link\">",
"     \"Epidemiology of tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/29/36310?source=see_link\">",
"     \"Parasitic pulmonary infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fungal pneumonia has become less common following improvements in antiretroviral treatment, but its true incidence remains unknown. Viral pathogens also contribute to the burden of pulmonary disease in patients infected with HIV. The clinical significance of isolating cytomegalovirus (CMV) from respiratory secretions is an area of particular controversy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/41/19093?source=see_link\">",
"     \"Cytomegalovirus infection as a cause of pulmonary disease in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of HAART has been associated with a reduction in some noninfectious pulmonary complications. As an example, the incidence of Kaposi's sarcoma (KS) has declined, most likely as a result of immune reconstitution. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12103?source=see_link\">",
"     \"AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis\"",
"    </a>",
"    .) HAART has also probably decreased the incidence of non-Hodgkin lymphoma (NHL) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/14,15\">",
"     14,15",
"    </a>",
"    ], although some data remain mixed; pulmonary involvement in these patients remains uncommon. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27206?source=see_link\">",
"     \"HIV infection and malignancy: Epidemiology and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite these improvements associated with HAART, noninfectious pulmonary diseases, including lung cancer and emphysema, are associated with HIV infection. In addition, organizing pneumonia, sarcoidosis, drug hypersensitivity, primary effusion lymphoma, foreign body granulomatosis, and other forms of lung disease can occasionally develop in HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/16-25\">",
"     16-25",
"    </a>",
"    ]. Lymphocytic interstitial pneumonitis, a rare interstitial lung disease in the general population, is seen with increased frequency in HIV-infected individuals, particularly children. The immune reconstitution syndrome can also affect the lung and mimic other conditions such as various infections and even lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/44/37575?source=see_link\">",
"     \"Emphysema-like disease in HIV infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30969?source=see_link\">",
"     \"AIDS-related lymphomas: Primary effusion lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/25/409?source=see_link\">",
"     \"Lymphoid interstitial pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial approach to any patient includes a good history and physical examination; the same is true for patients with known or suspected HIV infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Epidemiologic and environmental considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-infected IDUs are at an increased risk for the development of bacterial pneumonia and TB. The causative organisms and clinical features of bacterial pneumonia are generally similar in patients with and without HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    (TMP-SMX) prophylaxis for PCP was associated with a substantial reduction in the risk of developing bacterial pneumonia. In contrast, vaccination with pneumococcal vaccine did not appear to reduce this risk, at least in the era prior to HAART [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15449?source=see_link\">",
"     \"Bacterial pulmonary infections in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=see_link\">",
"     \"Immunizations in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A detailed assessment of any possible exposure to active TB is an important part of the medical history. Many cases of TB in HIV-infected patients represent newly acquired infection, rather than reactivation of old disease. Healthcare facilities, prisons, and homeless shelters are potential sources for transmission of TB. TB may accelerate the course of HIV disease since its occurrence is one factor predicting the development of subsequent OIs [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=see_link\">",
"     \"Epidemiology of tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is an increased incidence of pulmonary histoplasmosis and coccidioidomycosis in patients who live or travel in endemic areas (the Mississippi River Valley and the Southwest United States, respectively). Reactivation can occur especially in histoplasmosis; thus, patients who resided or spent time in endemic areas earlier in their lives are at risk for overt disease, as they become more immunosuppressed.",
"   </p>",
"   <p>",
"    In addition to infection caused by endemic fungi, parasitic disease results in substantial morbidity and mortality among this population worldwide. Responsible organisms include Toxoplasma gondii, Strongyloides stercoralis, Cryptosporidium, and Microsporidium. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/22/33129?source=see_link\">",
"     \"Toxoplasmosis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/29/36310?source=see_link\">",
"     \"Parasitic pulmonary infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients receiving HAART may develop recrudescence of diseases that have been dormant. As an example, patients with latent mycobacterial disease may develop fever, lymphadenopathy and pulmonary opacities following immune restoration [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/16\">",
"     16",
"    </a>",
"    ]. Sarcoidosis in HIV patients was uncommon in the pre-HAART era, however, there have been reports of patients developing sarcoid-like lesions following immunologic reconstitution with HAART [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic clues on physical examination are often unrelated to examination of the chest, but may suggest a pulmonary diagnosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The skin can show manifestations of pulmonary-associated bacterial, fungal, viral or neoplastic disorders. As an example, molluscum-like lesions seen in association with headache and fever should prompt a search for cryptococcosis [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Examination of the fundus and optic disc may suggest the presence of viral, fungal, or mycobacterial infection.",
"     </li>",
"     <li>",
"      Lymph nodes can be enlarged due to TB or lymphoma.",
"     </li>",
"     <li>",
"      Although unassociated with any particular pulmonary disorder, it is worth noting that HAART therapy has been associated with changes in body fat distribution and disordered fat metabolism called \"HIV-associated lipodystrophy.\" In some patients, the syndrome is characterized by marked subcutaneous fat depletion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      central visceral fat accumulation leading to truncal obesity, dorsocervical fat hump, and breast enlargement in both men and women [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/30\">",
"       30",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23352?source=see_link\">",
"       \"Lipodystrophic syndromes\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CD4 COUNT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with HIV, the occurrence of specific infections is closely correlated with the degree of impairment of host defenses. The sequence of pulmonary infections occurring in HIV-infected individuals parallels the depletion of CD4 lymphocytes. As a result, the CD4 count (or the \"stage\" of HIV) can provide information about the type of pulmonary disease to which the patient is susceptible. The stages of HIV are defined by the CD4 count. These include early (CD4 &gt;500",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ),",
"    </span>",
"    intermediate (CD4 200 to 500",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ),",
"    </span>",
"    advanced (CD4 100 to 200",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     )",
"    </span>",
"    and late stage disease (CD4 &lt;100",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/2/13353?source=see_link\">",
"     \"The stages and natural history of HIV infection\"",
"    </a>",
"    .) The following observations have been noted [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sinusitis and bronchitis can occur at any CD4 count.",
"     </li>",
"     <li>",
"      Bacterial pneumonia and TB can occur early in the course of HIV infection, when the CD4 count is &gt;500",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"      </span>",
"      and before AIDS-defining OIs or neoplasms occur. However, both occur more frequently as immune function declines.",
"     </li>",
"     <li>",
"      PCP, disseminated fungal disease, and CMV infection almost always occur when the CD4 counts are very low, usually below 200",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"       .",
"      </span>",
"     </li>",
"     <li>",
"      Human herpesvirus-8 (HHV-8)-related Kaposi's sarcoma occurs almost exclusively in HIV-infected men who have sex with men (MSM). As opposed to extensive and rapidly progressive Kaposi's sarcoma seen in the late stages of HIV infection, HHV-8 related Kaposi's sarcoma may appear extremely early in the course of HIV disease, in patients with CD4 cell counts &gt;500",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/32\">",
"       32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12103?source=see_link\">",
"       \"AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Pulmonary Complications of HIV Infection Study Group examined the incidence of pulmonary complications over five years, based upon HIV disease severity as measured by the CD4 count [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/31\">",
"     31",
"    </a>",
"    ]. The following patterns were noted.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute bronchitis was the most common of all respiratory infections in subjects with CD4 counts &ge;200",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"      </span>",
"      at study entry.",
"     </li>",
"     <li>",
"      In subjects with entry CD4 counts of 200 to 499",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"       ,",
"      </span>",
"      the incidence of infection caused by bacteria or PCP each increased an average of 40 percent per year.",
"     </li>",
"     <li>",
"      In subjects with entry CD4 counts &lt;200",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"       ,",
"      </span>",
"      acute bronchitis and bacterial pneumonia and PCP each occurred at high rates, without discernible trends over time, despite chemoprophylaxis in more than 80 percent after one year.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     IMAGING STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain chest radiographs, computed tomographic (CT) scanning, and (on occasion) nuclear imaging scans all may play a role in the diagnostic evaluation of an HIV-infected patient with pulmonary symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Chest radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain chest radiography is an appropriate initial imaging study for an HIV-infected patient presenting with unexplained pulmonary or constitutional symptoms. Any new abnormalities, including focal or diffuse opacities, nodules with or without cavitation, pleural effusions,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    intrathoracic adenopathy, should be pursued for a definitive diagnosis. Certain specific radiographic patterns may assist in this process (",
"    <a class=\"graphic graphic_table graphicRef73151 \" href=\"UTD.htm?31/18/32044\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Typical radiographic findings in patients with PCP include bilateral airspace infiltrates, often characterized as having a finely granular, reticular, or \"ground glass\" appearance [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/33\">",
"       33",
"      </a>",
"      ]. However, nodular densities, lobar consolidation, cystic lesions, upper lobe opacities, and pneumothoraces can all be seen. Aerosolized",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/43/22199?source=see_link\">",
"       pentamidine",
"      </a>",
"      prophylaxis appears to increase the probability of an atypical radiographic presentation of PCP infection [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. Some patients with PCP have normal radiographs. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7577?source=see_link\">",
"       \"Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      HIV-infected patients with pulmonary TB often present with atypical radiographs. In early studies, post-primary (\"typical\") patterns, with upper lobe opacification",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cavitation, were seen in only 20 to 30 percent of patients with pulmonary TB [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]. Findings compatible with primary infection, including intrathoracic adenopathy, lower lobe opacities,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pleural effusions, were present in up to 35 percent of these patients [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]. A subsequent study, comparing the radiographic presentation of HIV-associated TB in the pre- and post-HAART era, found that the incidence of \"typical\" post-primary chest radiographic changes increased from 25 to 45 percent following the introduction of HAART [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/37\">",
"       37",
"      </a>",
"      ]. The chest radiograph tends to correlate with the CD4 count; patients with CD4 counts above 200",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"      </span>",
"      more commonly have a post-primary (\"typical\") pattern, while patients with CD4 counts below 200",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"      </span>",
"      tend to have radiographs that are normal or compatible with primary TB infection [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One study found that HIV patients with abnormal chest radiographs (including",
"      <span class=\"nowrap\">",
"       nodules/masses,",
"      </span>",
"      opacities, cavities, lymphadenopathy, and effusions) and absence of pulmonary symptoms had a high incidence of infectious disorders, especially typical and atypical mycobacterial diseases [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/39\">",
"       39",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=see_link\">",
"       \"Mycobacterium avium complex (MAC) infections in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Opacities localized to a segment or lobe, particularly if they contain air bronchograms, are suggestive of bacterial pneumonia. The probability is even greater when observed in patients with CD4 lymphocyte counts &gt;200",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"       .",
"      </span>",
"      A majority (60 to 90 percent) of HIV-infected patients with bacterial pneumonia will have localized opacities. Diffuse opacities have been described, particularly in patients with Haemophilus influenzae pneumonia [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/40-42\">",
"       40-42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with HIV are at increased risk of pulmonary and systemic infection caused by Rhodococcus equi, a Nocardia-like organism associated with cavitary pneumonia and pleuropericardial effusion [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/43-45\">",
"       43-45",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18791?source=see_link\">",
"       \"Clinical features; diagnosis; therapy; and prevention of Rhodococcus equi infections\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Chest CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest CT scans have become an important part of the diagnostic evaluation of HIV patients with pulmonary symptoms. Chest CTs are more sensitive than plain chest radiographs in the detection of early interstitial lung disease, lymphadenopathy, and nodules. In a study of HIV-infected patients with evidence of pulmonary disease on chest CT, 17 percent had normal findings reported on plain chest radiograph [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/46\">",
"     46",
"    </a>",
"    ]. Intrathoracic adenopathy is a frequent chest CT finding in HIV-infected patients; one study of 318 patients found that 35 percent had evidence of lymphadenopathy. Among these patients, typical and atypical mycobacterial disease, bacterial pneumonia, and lymphoma were the most common diagnoses [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17032?source=see_link\">",
"     \"Principles of computed tomography of the chest\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"     \"High resolution computed tomography of the lungs\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chest CT scans have a greater ability than chest radiographs to identify and characterize pulmonary nodules both in HIV- and non-HIV-infected patients. Nodules (with or without cavitation) in HIV patients can result from infection (especially bacterial pneumonia and mycobacterial disease) or malignancy (particularly lymphoma). A biopsy, usually CT-guided transthoracic needle aspirate, is often required to make a definitive diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/34/14888?source=see_link\">",
"     \"Differential diagnosis and evaluation of multiple pulmonary nodules\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chest CTs are also helpful in identifying certain patterns that may lead to a specific diagnosis. As an example, one prospective study evaluated the accuracy of high resolution CT scans (HRCT) in distinguishing between PCP and other causes of lung disease in 30 patients with CD4 counts",
"    <span class=\"nowrap\">",
"     &lt;200/mm",
"     <sup>",
"      3",
"     </sup>",
"     ,",
"    </span>",
"    pulmonary symptoms, and nondiagnostic chest radiographs [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/50\">",
"     50",
"    </a>",
"    ]. The diagnosis \"suggestive of PCP\" was applied to cases showing a diffuse or ground glass pattern predominately in the upper lobes with or without cystic changes. Other findings such as \"tree in bud\" appearance, consolidation, bronchiectasis, and lymphadenopathy were classified as \"not suggestive of PCP.\" The sensitivity, specificity, positive predictive and, negative predictive values of the HRCT for the diagnosis for PCP were 100, 83.3, 90.5 and 100 percent, respectively. The authors suggest that HRCT is a reliable method for distinguishing PCP from other infectious processes in patients with HIV; however, not all experts share this view. (See",
"    <a class=\"local\" href=\"#H30\">",
"     'Empiric treatment of PCP'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Nuclear scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various forms of nuclear scanning have been used to evaluate HIV-infected patients with pulmonary symptoms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although highly sensitive for detecting PCP, gallium citrate (67 gallium) lung scanning has limited utility in the diagnostic evaluation of HIV-infected patients with pulmonary symptoms since this study is nonspecific.",
"     </li>",
"     <li>",
"      Kaposi's sarcoma is positive on Thallium-201 (TI-201) scans but negative on Gallium citrate (67 gallium) scans. This type of imaging may be helpful in patients where lung tissue sampling is not feasible and there is no cutaneous disease.",
"     </li>",
"     <li>",
"      Positron emission tomography (PET) scanning has been used to evaluate opportunistic infections or malignancies; however, since false positive scans have been associated with high levels of HIV RNA, PET scanning may not offer significant advantages to other imaging modalities that are not affected by clinical status [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/51\">",
"       51",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/28/28102?source=see_link\">",
"       \"Thoracic positron emission tomography\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PHYSIOLOGIC STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physiologic studies, including measurements of pulmonary function and gas exchange, may be useful in the evaluation of HIV-infected patients with pulmonary symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Arterial blood gas analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of arterial blood gases or oximetry performed before and after exercise is helpful to identify pulmonary disease in HIV-infected patients who are symptomatic but have normal chest radiographs. In a study of HIV patients with documented PCP, they failed to demonstrate a decrease in alveolar-to-arterial oxygen difference between rest and exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/52\">",
"     52",
"    </a>",
"    ]. Hence, patients who had a decrease in the (A-a) oxygen gradient with exercise were unlikely to have PCP. The authors concluded that this test makes is useful for PCP screening in symptomatic patients especially with normal chest imaging studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link\">",
"     \"Oxygenation and mechanisms of hypoxemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a similar report, other investigators found that desaturation below 90 percent occurred in 74 percent of patients with PCP who rode a bicycle ergometer for 10 minutes [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/53\">",
"     53",
"    </a>",
"    ]. Although the use of pulse oximetry is less sensitive, it has the advantage of estimating oxygen saturation without the need for drawing arterial blood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=see_link\">",
"     \"Pulse oximetry\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Diffusing capacity for carbon monoxide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of the diffusing capacity for carbon monoxide (DLCO) is a sensitive (though nonspecific) marker for pulmonary parenchymal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/54\">",
"     54",
"    </a>",
"    ]. In PCP, the DLCO may decrease before the development of interstitial infiltrates on chest radiograph, and in the absence of resting hypoxemia. Thus, when the DLCO is abnormal (&lt;80 percent of predicted) in a symptomatic patient, even with a normal chest radiograph, further diagnostic evaluation is generally indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7400?source=see_link\">",
"     \"Diffusing capacity for carbon monoxide\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SPUTUM ANALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Analysis of spontaneously expectorated sputum is used primarily in the diagnosis of TB. Induced sputum, if positive, is diagnostic for PCP. The value of sputum induction and analysis in the setting of other pulmonary infections is unknown. The utility of PCR for the detection of Pneumocystis in oral washes remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/56\">",
"     56",
"    </a>",
"    ]",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Role in tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A sputum sample for mycobacterial smear and culture is the best technique for diagnosing pulmonary TB. Acid-fast staining of expectorated sputum is positive in 30 to 89 percent of patients with TB (",
"    <a class=\"graphic graphic_picture graphicRef75210 \" href=\"UTD.htm?39/19/40255\">",
"     picture 1",
"    </a>",
"    ), while cultures are positive in 85 to 100 percent of patients. The diagnostic yield can be improved by collection of multiple sputum samples. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While induced sputum is not superior to a good expectorated sample, it is helpful in patients who are suspected to have TB but who are unable to produce sputum. A number of studies have evaluated sputum induction versus bronchoscopy in patients infected with HIV. One study found that sputum induction is a safe procedure with a high diagnostic yield and that is equivalent to results of fiberoptic bronchoscopy for the diagnosis of pulmonary TB [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/57\">",
"     57",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Induced sputum may be diagnostic in the setting of tuberculous pleuritis. One study noted the yield of sputum induction cultures for M. tuberculosis was 55 percent in patients with normal lung parenchyma in conjunction with a pleural effusion. The authors concluded that the yield from induced sputum cultures is high in patients with pleural TB, even if the pulmonary parenchyma has no abnormalities detected on chest radiographs [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/58\">",
"     58",
"    </a>",
"    ]. However, this study was conducted in an area where TB is common, and the more generalized diagnostic validity of this approach has not been confirmed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22261?source=see_link\">",
"     \"Tuberculous pleural effusions in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A number of rapid diagnostic tests that can be performed on sputum have been developed in an effort to improve diagnostic yield and expedite evaluation. PCR-based testing is the most prominent of these techniques. While the specificity for PCR in the diagnosis of TB is quite high, the sensitivity ranges widely, and appears to be best on smear-positive specimens. Hence, a positive PCR test is helpful in making a quick diagnosis of M. tuberculosis, but a negative test, especially on a smear-negative specimen, does not exclude the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Role in PCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;While the specificity of induced sputum for PCP approaches 100 percent, the sensitivity of this test varies between 55 to 92 percent. This marked variability is related to the prevalence of PCP in the population being studied and to the experience of the institution performing, processing, and interpreting the tests. The staining technique may also increase the sensitivity; PCR may be superior to immunofluorescence [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. Earlier studies showed that cost effectiveness and utility depended upon the prevalence of PCP in a given population [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/62\">",
"     62",
"    </a>",
"    ]. More recent studies have confirmed that HAART and prophylaxis against PCP have decreased the incidence of disease in this population, which may reduce the usefulness of sputum induction for the diagnosis of PCP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/60\">",
"     60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7577?source=see_link\">",
"     \"Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     OTHER NONINVASIVE TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of miscellaneous noninvasive diagnostic tests have been used in specific clinical settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Antigen and antibody testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing is generally of little value in the diagnosis of acute infections in the HIV-infected host. Notable exceptions include assays designed to detect Histoplasma polysaccharide antigen (HPA) and cryptococcal antigen. HPA can be detected in the urine of 90 percent of patients with disseminated infection, and 75 percent of those with diffuse acute pulmonary histoplasmosis [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/63\">",
"     63",
"    </a>",
"    ]. The sensitivity of antigen detection is highest when urine and serum are tested. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9321?source=see_link\">",
"     \"Diagnosis and treatment of disseminated histoplasmosis in non-HIV-infected patients\"",
"    </a>",
"    .) The IDSA practice guidelines for the management of patients with histoplasmosis, as well as other IDSA guidelines, can be accessed through the Infectious Diseases Society of America's website [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cryptococcal antigen is less likely to be positive in localized cryptococcal pneumonia compared with disseminated cryptococcosis. However, its presence is useful in confirming the diagnosis because the assay has excellent specificity. Following titers of HPA and cryptococcal antigen may also be helpful in evaluating response to therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/8/13449?source=see_link\">",
"     \"Cryptococcal infection outside the central nervous system\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Measurement of serum antibodies to PCP and CMV is not clinically applicable, since they do not distinguish active from latent disease. The diagnostic utility, if any, of PCR-based assays of serum, oropharyngeal washes, or sputum has yet to be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Polymerase chain reaction testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A prospective study of 55 HIV-infected patients with pulmonary symptoms demonstrated an important role for real-time polymerase chain reaction testing (RT-PCR) of bronchoalveolar samples [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/65\">",
"     65",
"    </a>",
"    ]. Nearly one-fifth of all patients were positive for at least one respiratory virus including coronavirus, influenza, and parainfluenza. Since no other pathogens were found in the majority of cases, these were felt to be responsible for the pulmonary symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Smear and culture of peripheral blood",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cultures of blood for Histoplasma capsulatum and mycobacteria may occasionally provide a definitive diagnosis. In patients with disseminated histoplasmosis, the highest yield is from bone marrow or blood cultures, which are positive in more than 75 percent of cases. Smears of peripheral blood can provide a rapid diagnosis in approximately 28 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/66\">",
"     66",
"    </a>",
"    ]. Blood cultures are positive in 26 to 42 percent of HIV-infected patients with TB, and the frequency of positive results is inversely related to the CD4 count [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/38\">",
"     38",
"    </a>",
"    ]. Blood cultures for CMV are not helpful since viremia may be present without pneumonitis and vice versa. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/41/19093?source=see_link\">",
"     \"Cytomegalovirus infection as a cause of pulmonary disease in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Serum lactate dehydrogenase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of serum lactate dehydrogenase (LDH) is helpful in screening patients suspected of having PCP. One study of 54 patients with PCP found that 93 percent had an abnormal LDH value [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/67\">",
"     67",
"    </a>",
"    ]. Although LDH is sensitive for the diagnosis of PCP, its specificity is quite low. Thus, a normal LDH value makes the diagnosis unlikely. Other diseases associated with markedly elevated LDH values include lymphoma, TB, and toxoplasmosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/22/33129?source=see_link\">",
"     \"Toxoplasmosis in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Skin testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the exception of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    , other skin testing of HIV-infected patients is not useful. Therapy for latent tuberculosis infection (LTBI) is indicated for HIV-infected patients who have a positive tuberculin skin test (&gt;5 mm) without active TB [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/68\">",
"     68",
"    </a>",
"    ]. Since the positivity of the tuberculin test depends upon the CD4 count, a negative test in patients with CD4 counts &lt;300",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    does",
"    <strong>",
"     not",
"    </strong>",
"    rule out either active or latent infection. Tuberculin skin tests should",
"    <strong>",
"     not",
"    </strong>",
"    be relied upon to make or rule out the diagnosis of active pulmonary TB. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=see_link\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Annual",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    screening in asymptomatic tuberculin-negative individuals is recommended if they are infected with HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/69\">",
"     69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4298?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     INVASIVE TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major invasive tests that are used to diagnose pulmonary disease in HIV-infected patients include fiberoptic bronchoscopy, computed tomographic (CT)-guided transthoracic needle aspiration (TTNA), and surgical lung biopsy using either video-assisted thoracoscopic surgery (VATS) or open thoracotomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Fiberoptic bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of its high yield and low complication rate, fiberoptic bronchoscopy (FOB) remains the procedure of choice for diagnosing many pulmonary diseases in HIV-infected patients (",
"    <a class=\"graphic graphic_table graphicRef59598 \" href=\"UTD.htm?35/50/36651\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/70\">",
"     70",
"    </a>",
"    ]. Although the indications for bronchoscopy changed little between 1990 and 1998, one study found the rates of pulmonary infection requiring bronchoscopy for definitive diagnosis declined by 60 percent over that time period, probably on the basis of improved noninvasive testing and increased reliance on empiric therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=see_link\">",
"     \"Flexible bronchoscopy: Indications and contraindications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The disorders most commonly diagnosed using FOB include infections caused by Pneumocystis",
"    <span class=\"nowrap\">",
"     carinii/(PCP),",
"    </span>",
"    mycobacterial, fungal, and viral pathogens. The yield of bronchoalveolar lavage (BAL) for the diagnosis of PCP is between 96 and 98 percent. Hence, the value of routine transbronchial biopsy in addition to BAL is controversial. Although biopsies slightly increase the risks of pneumothorax and hemorrhage, they may incrementally improve the diagnostic yield in PCP and other infections [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/72\">",
"     72",
"    </a>",
"    ]. If transbronchial biopsy is contraindicated, BAL alone continues to have a good overall diagnostic yield, justifying its use as a sole procedure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=see_link\">",
"     \"Flexible bronchoscopy: Equipment, procedure, and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Biopsies can provide tissue specimens allowing diagnosis of noninfectious disorders including Kaposi's sarcoma (KS), lymphocytic interstitial pneumonitis, and nonspecific interstitial pneumonitis, which cannot be reliably diagnosed on the basis of BAL findings. When mediastinal adenopathy is present, a diagnosis may sometimes be made by sampling nodes with a transtracheal (Wang) needle aspiration. The diagnostic yield of this procedure varies and depends upon the experience of the operator and the cytopathologist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/35/3642?source=see_link\">",
"     \"Transbronchial needle aspiration\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of fiberoptic bronchoscopy in the rapid diagnosis of tuberculosis (TB) in HIV-infected patients remains controversial. Several studies have shown that bronchoscopy provided an early diagnosis in patients who had negative sputum smears 34 to 38 percent of the time [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. In one study, transbronchial biopsy provided the exclusive means for rapid diagnosis in 6 of 59 HIV-infected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/73\">",
"     73",
"    </a>",
"    ]. However, studies directly comparing induced sputum to bronchoscopy have found the yield of induced sputum superior or equal to that of bronchoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/75\">",
"     75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several conclusions can be drawn from these studies regarding the diagnosis of TB in patients infected with HIV:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Expectorated sputum, when available, has a high yield for diagnosing pulmonary TB and should be the initial procedure of choice [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/76\">",
"       76",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      If expectorated sputum smears are negative, or if the patient cannot produce sputum, sputum induction should be performed. Bronchoscopy has a reasonable yield, but it is the procedure associated with the highest risk of transmission of TB to medical personnel.",
"     </li>",
"     <li>",
"      If bronchoscopy is to be used for rapid diagnosis of TB, a transbronchial biopsy should be considered in addition to washings and lavage [",
"      <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/73,74\">",
"       73,74",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Bacterial infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fiberoptic bronchoscopy is rarely performed in HIV-infected patients for the diagnosis of bacterial infection. Rather the procedure is used to diagnose PCP or TB. Occasionally, an HIV-infected patient with nosocomial pneumonia will undergo bronchoscopy. To circumvent contamination from the upper airways, a double lumen catheter system or a protected BAL is recommended. Semi-quantitative cultures of the collected specimens should be performed. Some investigators have reported high sensitivities and specificities with these techniques; however, others have found a high false positive rate and, more importantly, false negative results [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/77-79\">",
"     77-79",
"    </a>",
"    ]. All studies have shown that any antibiotic usage before the bronchoscopic procedure markedly decreases its sensitivity.",
"   </p>",
"   <p>",
"    The value of FOB and nonbronchoscopic evaluation of ventilator-associated pneumonia in the management of patients with respiratory failure are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24040?source=see_link\">",
"     \"Clinical presentation and diagnosis of ventilator-associated pneumonia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Cytomegalovirus infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of cytomegalovirus (CMV) as a pulmonary pathogen in patients with AIDS has not been fully defined. The virus is often found in cultures of BAL fluid in association with other organisms including PCP and TB. Since most patients respond to treatment of these other infectious agents, the clinical relevance of CMV retrieved bronchoscopically is questionable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/41/19093?source=see_link\">",
"     \"Cytomegalovirus infection as a cause of pulmonary disease in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cultures of BAL fluid are not established as a test for CMV pneumonitis. BAL cytology, which can demonstrate the cytopathic effects of CMV, is probably a more specific test than CMV culture. However, there is no clear correlation of cytopathic effect with either pneumonitis or with morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/80\">",
"     80",
"    </a>",
"    ]. Transbronchial biopsies are more likely to be specific for CMV pneumonitis but are insensitive due to the patchy nature of the disease.",
"   </p>",
"   <p>",
"    In summary, the following points can be made about CMV pneumonitis in HIV-infected patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      BAL culture or cells showing cytopathic changes compatible with CMV in the HIV-infected patient are not specific tests for CMV pneumonitis.",
"     </li>",
"     <li>",
"      When CMV is isolated from bronchoscopic specimens and concomitant pathogens are also present, treatment of only the concomitant pathogens is recommended.",
"     </li>",
"     <li>",
"      When CMV is isolated from bronchoscopic specimens, treatment is recommended only in the presence of symptomatic pulmonary disease and in the absence of other treatable pulmonary infections.",
"     </li>",
"     <li>",
"      Treatment is",
"      <strong>",
"       not",
"      </strong>",
"      recommended when CMV is isolated in bronchoscopic specimens from an asymptomatic person.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     CT-guided TTNA",
"    </span>",
"    &nbsp;&mdash;&nbsp;TTNA using CT guidance has a high yield in diagnosing the cause of peripheral nodules and localized infiltrates; however, the yield is much lower in patients with diffuse disease. In a study of patients with focal chest or mediastinal abnormalities on CT scan, a diagnosis was established in 27 of 32 cases (84 percent) using TTNA [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/81\">",
"     81",
"    </a>",
"    ]. Although infectious agents were isolated in most of these patients, bronchogenic carcinoma was also diagnosed.",
"   </p>",
"   <p>",
"    Although TTNA has been shown to be a safe and effective procedure for the evaluation of focal thoracic disease, it is not widely used. The reasons for this include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The small size of the samples obtained limits the number of studies that can be performed.",
"     </li>",
"     <li>",
"      The diagnostic yield is lower than that of FOB for the diagnosis of interstitial disease.",
"     </li>",
"     <li>",
"      There is a higher complication rate compared to FOB.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Surgical lung biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical lung biopsy remains the procedure with the greatest sensitivity in the diagnosis of parenchymal lung disease. Thoracotomy and VATS can both be performed safely in HIV-infected patients. One study showed that in patients who had a nondiagnostic bronchoscopy, a definitive diagnosis was found in 13 of 18 patients (72 percent) who underwent open lung biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/82\">",
"     82",
"    </a>",
"    ]. Another study showed that results of an open lung biopsy led to a change in therapy in 15 of 25 patients, eight of whom improved clinically and were discharged from the hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/83\">",
"     83",
"    </a>",
"    ]. The authors outlined the following indications for open lung biopsy in HIV patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nondiagnostic bronchoscopy",
"     </li>",
"     <li>",
"      Failed medical therapy after a diagnostic bronchoscopy",
"     </li>",
"     <li>",
"      Failed empiric medical therapy after a nondiagnostic bronchoscopy",
"     </li>",
"     <li>",
"      Any of the above, in combination with a worsening chest radiograph",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even though no formal comparison of VATS and open lung biopsy has been made in HIV-infected patients, both procedures appear to be equivalent for obtaining diagnostic lung tissue. There may be less morbidity associated with VATS, as these patients generally require fewer days in hospital and less time with chest tube drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/83\">",
"     83",
"    </a>",
"    ]. If the patient cannot tolerate single lung ventilation, which is necessary during VATS, or if the lesion cannot be reached through a thoracoscope, then an open thoracotomy should be performed. In general, the choice of procedure is best left to the surgeon. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/2/15400?source=see_link\">",
"     \"Preoperative evaluation for lung resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     EMPIRIC TREATMENT OF PCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before the advent of HAART, when PCP was the most common pulmonary entity presenting in HIV-infected patients in the United States, a number of clinicians prescribed empiric treatment of PCP for HIV-infected patients with pulmonary symptoms and radiographic findings consistent with PCP [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/84\">",
"     84",
"    </a>",
"    ]. Invasive procedures were reserved for those who did not respond within a few days [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/84\">",
"     84",
"    </a>",
"    ]. Even then, others argued that empiric therapy was inappropriate, since pathogens other than PCP were frequently responsible for opportunistic pulmonary infections. Furthermore, therapy for presumed PCP may be unnecessarily prolonged, potentially toxic, and at times contraindicated. As an example, patients receiving steroids theoretically may be harmed if they have bacterial or tuberculous pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/85,86\">",
"     85,86",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27593?source=see_link\">",
"     \"Treatment of Pneumocystis infection in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some studies show that there is no conclusive evidence that one approach results in a better outcome over the other [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/87\">",
"     87",
"    </a>",
"    ]; others have reported that patients who are treated empirically for PCP are more likely to die in the hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/88\">",
"     88",
"    </a>",
"    ]. Criteria for the clinical diagnosis of PCP were suggested, based upon the following combination of findings [",
"    <a class=\"abstract\" href=\"UTD.htm?19/43/20154/abstract/87\">",
"     87",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A history of dyspnea on exertion or unproductive cough of recent origin",
"     </li>",
"     <li>",
"      Radiographic evidence of diffuse bilateral interstitial lung disease",
"     </li>",
"     <li>",
"      Arterial hypoxemia",
"     </li>",
"     <li>",
"      Lack of evidence for bacterial pneumonia",
"     </li>",
"     <li>",
"      CD4 count less than 200",
"      <span class=\"nowrap\">",
"       cells/mm",
"       <sup>",
"        3",
"       </sup>",
"      </span>",
"     </li>",
"     <li>",
"      Lack of effective PCP prophylaxis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the HAART era, a number of factors have probably made the above argument moot.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PCP is decreasing in incidence among HIV-infected patients receiving antiretroviral therapy.",
"     </li>",
"     <li>",
"      Induced sputum with appropriate stains has improved the noninvasive diagnosis of PCP.",
"     </li>",
"     <li>",
"      PCP remains an AIDS-defining illness, which may alter the approach to antiretroviral therapy in an HIV-infected patient who has progressed to AIDS, as opposed to one who presents with an intercurrent bacterial pneumonia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, given the urgency for making a firm diagnosis and the lack of definitive data confirming the safety of empiric treatment, it seems prudent to establish a definitive diagnosis in most HIV-infected patients with new pulmonary symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radiographic evidence of new interstitial lung disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7577?source=see_link\">",
"     \"Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-infected patients are at increased risk of both infectious and noninfectious pulmonary diseases. Careful attention to historical detail and physical examination, combined with a rational approach to noninvasive testing, can provide a definitive diagnosis in many cases. Patients who require rapid diagnostic evaluation, or those who fail to respond to therapy should be considered for invasive diagnostic testing, including FOB and surgical lung biopsy. A diagnostic algorithm for the evaluation of HIV-infected patients with pulmonary symptoms, including options for empiric therapy and definitive diagnosis, is recommended (",
"    <a class=\"graphic graphic_figure graphicRef78591 \" href=\"UTD.htm?38/39/39550\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/1\">",
"      Jones JL, Hanson DL, Dworkin MS, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ 1999; 48:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/2\">",
"      Centers for Disease Control and Prevention (CDC). Twenty-five years of HIV/AIDS--United States, 1981-2006. MMWR Morb Mortal Wkly Rep 2006; 55:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/3\">",
"      Centers for Disease Control and Prevention (CDC). Disparities in diagnoses of HIV infection between blacks/African Americans and other racial/ethnic populations--37 states, 2005-2008. MMWR Morb Mortal Wkly Rep 2011; 60:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/4\">",
"      Hall HI, Hughes D, Dean HD, et al. HIV Infection - United States, 2005 and 2008. MMWR Surveill Summ 2011; 60 Suppl:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/5\">",
"      Beck JM, Rosen MJ, Peavy HH. Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop. Am J Respir Crit Care Med 2001; 164:2120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/6\">",
"      Boyton RJ. Infectious lung complications in patients with HIV/AIDS. Curr Opin Pulm Med 2005; 11:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/7\">",
"      Kanmogne GD. Noninfectious pulmonary complications of HIV/AIDS. Curr Opin Pulm Med 2005; 11:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/8\">",
"      Grubb JR, Moorman AC, Baker RK, Masur H. The changing spectrum of pulmonary disease in patients with HIV infection on antiretroviral therapy. AIDS 2006; 20:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/9\">",
"      Wolff AJ, O'Donnell AE. HIV-related pulmonary infections: a review of the recent literature. Curr Opin Pulm Med 2003; 9:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/10\">",
"      Sullivan JH, Moore RD, Keruly JC, Chaisson RE. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med 2000; 162:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/11\">",
"      Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/12\">",
"      Friedman LN, Williams MT, Singh TP, Frieden TR. Tuberculosis, AIDS, and death among substance abusers on welfare in New York City. N Engl J Med 1996; 334:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/13\">",
"      Uberti-Foppa C, Lillo F, Terreni MR, et al. Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease. Chest 1998; 113:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/14\">",
"      International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92:1823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/15\">",
"      Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001; 98:2339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/16\">",
"      Pomerantz RJ. Immune reconstitution syndrome in AIDS. Interview by Vicki Glaser. AIDS Patient Care STDS 2003; 17:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/17\">",
"      Haramati LB, Lee G, Singh A, et al. Newly diagnosed pulmonary sarcoidosis in HIV-infected patients. Radiology 2001; 218:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/18\">",
"      Matolcsy A. Primary effusional lymphoma: A new non-Hodgkin s lymphoma entity. Pathol Oncol Res 1999; 5:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/19\">",
"      Khater FJ, Moorman JP, Myers JW, et al. Bronchiolitis obliterans organizing pneumonia as a manifestation of AIDS: case report and literature review. J Infect 2004; 49:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/20\">",
"      D&iacute;az F, Collazos J, Martinez E, Mayo J. Bronchiolitis obliterans in a patient with HIV infection. Respir Med 1997; 91:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/21\">",
"      Morris DG, Jasmer RM, Huang L, et al. Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence. Chest 2003; 124:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/22\">",
"      Tobin-D'Angelo MJ, Hoteit MA, Brown KV, et al. Dapsone-induced hypersensitivity pneumonitis mimicking Pneumocystis carinii pneumonia in a patient with AIDS. Am J Med Sci 2004; 327:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/23\">",
"      Behrens GM, Stoll M, Schmidt RE. Pulmonary hypersensitivity reaction induced by efavirenz. Lancet 2001; 357:1503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/24\">",
"      Morris AM, Nishimura S, Huang L. Subacute hypersensitivity pneumonitis in an HIV infected patient receiving antiretroviral therapy. Thorax 2000; 55:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/25\">",
"      Nan DN, Fern&aacute;ndez-Ayala M, Iglesias L, et al. Talc granulomatosis. A differential diagnosis of interstitial lung disease in HIV patients. Chest 2000; 118:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/26\">",
"      Stoll M, Schmidt RE. Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART. Curr HIV/AIDS Rep 2004; 1:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/27\">",
"      Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995; 333:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/28\">",
"      Munsiff SS, Alpert PL, Gourevitch MN, et al. A prospective study of tuberculosis and HIV disease progression. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/29\">",
"      Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol 1992; 27:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/30\">",
"      Wanke CA, Falutz JM, Shevitz A, et al. Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus. Clin Infect Dis 2002; 34:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/31\">",
"      Wallace JM, Hansen NI, Lavange L, et al. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study cohort. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1997; 155:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/32\">",
"      Rezza G, Andreoni M, Dorrucci M, et al. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst 1999; 91:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/33\">",
"      Crans CA Jr, Boiselle PM. Imaging features of Pneumocystis carinii pneumonia. Crit Rev Diagn Imaging 1999; 40:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/34\">",
"      Levine SJ, Masur H, Gill VJ, et al. Effect of aerosolized pentamidine prophylaxis on the diagnosis of Pneumocystis carinii pneumonia by induced sputum examination in patients infected with the human immunodeficiency virus. Am Rev Respir Dis 1991; 144:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/35\">",
"      Long R, Maycher B, Scalcini M, Manfreda J. The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest 1991; 99:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/36\">",
"      Barnes PF, Bloch AB, Davidson PT, Snider DE Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324:1644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/37\">",
"      Girardi E, Palmieri F, Cingolani A, et al. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 26:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/38\">",
"      Jones BE, Young SM, Antoniskis D, et al. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993; 148:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/39\">",
"      Gold JA, Rom WN, Harkin TJ. Significance of abnormal chest radiograph findings in patients with HIV-1 infection without respiratory symptoms. Chest 2002; 121:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/40\">",
"      Aviram G, Boiselle PM. Imaging features of bacterial respiratory infections in AIDS. Curr Opin Pulm Med 2004; 10:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/41\">",
"      Cordero E, Pach&oacute;n J, Rivero A, et al. Haemophilus influenzae pneumonia in human immunodeficiency virus-infected patients. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Clin Infect Dis 2000; 30:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/42\">",
"      Baril L, Astagneau P, Nguyen J, et al. Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study. Clin Infect Dis 1998; 26:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/43\">",
"      Arlotti M, Zoboli G, Moscatelli GL, et al. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand J Infect Dis 1996; 28:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/44\">",
"      Hsueh PR, Hung CC, Teng LJ, et al. Report of invasive Rhodococcus equi infections in Taiwan, with an emphasis on the emergence of multidrug-resistant strains. Clin Infect Dis 1998; 27:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/45\">",
"      Torres-Tortosa M, Arrizabalaga J, Villanueva JL, et al. Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases. Chest 2003; 123:1970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/46\">",
"      Knollmann FD, Gr&uuml;newald T, Neitzert J, et al. Thoracic computed tomography of patients infected with the human immunodeficiency virus: relevance for the course of disease. J Thorac Imaging 1999; 14:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/47\">",
"      Jasmer RM, Gotway MB, Creasman JM, et al. Clinical and radiographic predictors of the etiology of computed tomography-diagnosed intrathoracic lymphadenopathy in HIV-infected patients. J Acquir Immune Defic Syndr 2002; 31:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/48\">",
"      Jasmer RM, Edinburgh KJ, Thompson A, et al. Clinical and radiographic predictors of the etiology of pulmonary nodules in HIV-infected patients. Chest 2000; 117:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/49\">",
"      Bazot M, Cadranel J, Benayoun S, et al. Primary pulmonary AIDS-related lymphoma: radiographic and CT findings. Chest 1999; 116:1282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/50\">",
"      Hidalgo A, Falc&oacute; V, Maule&oacute;n S, et al. Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non- Pneumocystis carinii pneumonia in AIDS patients. Eur Radiol 2003; 13:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/51\">",
"      O'Doherty MJ, Barrington SF, Campbell M, et al. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 1997; 38:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/52\">",
"      Stover DE, Greeno RA, Gagliardi AJ. The use of a simple exercise test for the diagnosis of Pneumocystis carinii pneumonia in patients with AIDS. Am Rev Respir Dis 1989; 139:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/53\">",
"      Smith DE, Forbes A, Davies S, et al. Diagnosis of Pneumocystis carinii pneumonia in HIV antibody positive patients by simple outpatient assessments. Thorax 1992; 47:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/54\">",
"      Stover DE, White DA, Romano PA, et al. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med 1985; 78:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/55\">",
"      Huang L, Stansell J, Osmond D, et al. Performance of an algorithm to detect Pneumocystis carinii pneumonia in symptomatic HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Chest 1999; 115:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/56\">",
"      Helweg-Larsen J, Jensen JS, Benfield T, et al. Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples. J Clin Microbiol 1998; 36:2068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/57\">",
"      Conde MB, Soares SL, Mello FC, et al. Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis: experience at an acquired immune deficiency syndrome reference center in Rio de Janeiro, Brazil. Am J Respir Crit Care Med 2000; 162:2238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/58\">",
"      Conde MB, Loivos AC, Rezende VM, et al. Yield of sputum induction in the diagnosis of pleural tuberculosis. Am J Respir Crit Care Med 2003; 167:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/59\">",
"      Al Zahrani K, Al Jahdali H, Poirier L, et al. Accuracy and utility of commercially available amplification and serologic tests for the diagnosis of minimal pulmonary tuberculosis. Am J Respir Crit Care Med 2000; 162:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/60\">",
"      Turner D, Schwarz Y, Yust I. Induced sputum for diagnosing Pneumocystis carinii pneumonia in HIV patients: new data, new issues. Eur Respir J 2003; 21:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/61\">",
"      Caliendo AM, Hewitt PL, Allega JM, et al. Performance of a PCR assay for detection of Pneumocystis carinii from respiratory specimens. J Clin Microbiol 1998; 36:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/62\">",
"      Glenny RW, Pierson DJ. Cost reduction in diagnosing Pneumocystis carinii pneumonia. Sputum induction versus bronchoalveolar lavage as the initial diagnostic procedure. Am Rev Respir Dis 1992; 145:1425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/63\">",
"      Wheat J. Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature. Medicine (Baltimore) 1997; 76:339.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.idsociety.org/Content.aspx?id=9088 (Accessed on December 12, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/65\">",
"      Garbino J, Inoubli S, Mossdorf E, et al. Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infection. AIDS 2008; 22:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/66\">",
"      Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/67\">",
"      Zaman MK, White DA. Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia. Diagnostic and prognostic significance. Am Rev Respir Dis 1988; 137:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/68\">",
"      Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/69\">",
"      Katz DJ, Hall WN, Keon NB, Crane LR. HIV testing in patients with tuberculosis. Physician response to national recommendations. Am Rev Respir Dis 1993; 147:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/70\">",
"      Narayanswami G, Salzman SH. Bronchoscopy in the human immunodeficiency virus-infected patient. Semin Respir Infect 2003; 18:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/71\">",
"      Taggart S, Breen R, Goldsack N, et al. The changing pattern of bronchoscopy in an HIV-infected population. Chest 2002; 122:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/72\">",
"      Salzman SH. Bronchoscopic techniques for the diagnosis of pulmonary complications of HIV infection. Semin Respir Infect 1999; 14:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/73\">",
"      Salzman SH, Schindel ML, Aranda CP, et al. The role of bronchoscopy in the diagnosis of pulmonary tuberculosis in patients at risk for HIV infection. Chest 1992; 102:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/74\">",
"      Kennedy DJ, Lewis WP, Barnes PF. Yield of bronchoscopy for the diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Chest 1992; 102:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/75\">",
"      Anderson C, Inhaber N, Menzies D. Comparison of sputum induction with fiber-optic bronchoscopy in the diagnosis of tuberculosis. Am J Respir Crit Care Med 1995; 152:1570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/76\">",
"      Vray M, Germani Y, Chan S, et al. Clinical features and etiology of pneumonia in acid-fast bacillus sputum smear-negative HIV-infected patients hospitalized in Asia and Africa. AIDS 2008; 22:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/77\">",
"      Chastre J, Viau F, Brun P, et al. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am Rev Respir Dis 1984; 130:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/78\">",
"      Meduri GU, Beals DH, Maijub AG, Baselski V. Protected bronchoalveolar lavage. A new bronchoscopic technique to retrieve uncontaminated distal airway secretions. Am Rev Respir Dis 1991; 143:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/79\">",
"      Thorpe JE, Baughman RP, Frame PT, et al. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis 1987; 155:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/80\">",
"      Hayner CE, Baughman RP, Linnemann CC Jr, Dohn MN. The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest 1995; 107:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/81\">",
"      Gruden JF, Klein JS, Webb WR. Percutaneous transthoracic needle biopsy in AIDS: analysis in 32 patients. Radiology 1993; 189:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/82\">",
"      Fitzgerald W, Bevelaqua FA, Garay SM, Aranda CP. The role of open lung biopsy in patients with the acquired immunodeficiency syndrome. Chest 1987; 91:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/83\">",
"      Trachiotis GD, Hafner GH, Hix WR, Aaron BL. Role of open lung biopsy in diagnosing pulmonary complications of AIDS. Ann Thorac Surg 1992; 54:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/84\">",
"      Bach PB, Calhoun EA, Bennett CL. The relation between physician experience and patterns of care for patients with AIDS-related Pneumocystis carinii pneumonia: results from a survey of 1,500 physicians in the United States. Chest 1999; 115:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/85\">",
"      Tu JV, Biem HJ, Detsky AS. Bronchoscopy versus empirical therapy in HIV-infected patients with presumptive Pneumocystis carinii pneumonia. A decision analysis. Am Rev Respir Dis 1993; 148:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/86\">",
"      Luce JM, Stover DE. Controversies in pulmonary medicine. Presumed Pneumocystis carinii pneumonia should be treated empirically in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1988; 138:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/87\">",
"      Pozniak AL, Tung KT, Swinburn CR, et al. Clinical and bronchoscopic diagnosis of suspected pneumonia related to AIDS. Br Med J (Clin Res Ed) 1986; 293:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?19/43/20154/abstract/88\">",
"      Horner RD, Bennett CL, Rodriguez D, et al. Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1995; 152:1435.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3721 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-89.32.226.102-D86B8ADF8C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20154=[""].join("\n");
var outline_f19_43_20154=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Pulmonary diseases and HIV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Epidemiologic and environmental considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CD4 COUNT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      IMAGING STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Chest radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Chest CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Nuclear scanning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PHYSIOLOGIC STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Arterial blood gas analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Diffusing capacity for carbon monoxide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SPUTUM ANALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Role in tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Role in PCP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      OTHER NONINVASIVE TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Antigen and antibody testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Polymerase chain reaction testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Smear and culture of peripheral blood",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Serum lactate dehydrogenase",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Skin testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      INVASIVE TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Fiberoptic bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Bacterial infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Cytomegalovirus infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      CT-guided TTNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Surgical lung biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      EMPIRIC TREATMENT OF PCP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3721\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3721|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/39/39550\" title=\"figure 1\">",
"      HIV with pulmonary symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3721|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/19/40255\" title=\"picture 1\">",
"      MTB in sputum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3721|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/18/32044\" title=\"table 1\">",
"      Differential diagnosis of pulmonary infiltrate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/50/36651\" title=\"table 2\">",
"      Bronchoscopic yield in HIV",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12103?source=related_link\">",
"      AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30969?source=related_link\">",
"      AIDS-related lymphomas: Primary effusion lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15449?source=related_link\">",
"      Bacterial pulmonary infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18791?source=related_link\">",
"      Clinical features; diagnosis; therapy; and prevention of Rhodococcus equi infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7577?source=related_link\">",
"      Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/30/24040?source=related_link\">",
"      Clinical presentation and diagnosis of ventilator-associated pneumonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/8/13449?source=related_link\">",
"      Cryptococcal infection outside the central nervous system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/41/19093?source=related_link\">",
"      Cytomegalovirus infection as a cause of pulmonary disease in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/6/9321?source=related_link\">",
"      Diagnosis and treatment of disseminated histoplasmosis in non-HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=related_link\">",
"      Diagnosis of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/34/14888?source=related_link\">",
"      Differential diagnosis and evaluation of multiple pulmonary nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7400?source=related_link\">",
"      Diffusing capacity for carbon monoxide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/44/37575?source=related_link\">",
"      Emphysema-like disease in HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=related_link\">",
"      Epidemiology of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/10/1194?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of tuberculosis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=related_link\">",
"      Flexible bronchoscopy: Equipment, procedure, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=related_link\">",
"      Flexible bronchoscopy: Indications and contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27206?source=related_link\">",
"      HIV infection and malignancy: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37273?source=related_link\">",
"      Immunizations in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23352?source=related_link\">",
"      Lipodystrophic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/25/409?source=related_link\">",
"      Lymphoid interstitial pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38777?source=related_link\">",
"      Mycobacterium avium complex (MAC) infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=related_link\">",
"      Oxygenation and mechanisms of hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/29/36310?source=related_link\">",
"      Parasitic pulmonary infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/2/15400?source=related_link\">",
"      Preoperative evaluation for lung resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17032?source=related_link\">",
"      Principles of computed tomography of the chest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=related_link\">",
"      Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=related_link\">",
"      Selecting antiretroviral regimens for the treatment naive HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/2/13353?source=related_link\">",
"      The stages and natural history of HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/28/28102?source=related_link\">",
"      Thoracic positron emission tomography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/22/33129?source=related_link\">",
"      Toxoplasmosis in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/35/3642?source=related_link\">",
"      Transbronchial needle aspiration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27593?source=related_link\">",
"      Treatment of Pneumocystis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/12/4298?source=related_link\">",
"      Treatment of latent tuberculosis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/47/22261?source=related_link\">",
"      Tuberculous pleural effusions in HIV-infected patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f19_43_20155="Options breast ovar ca PI";
var content_f19_43_20155=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F69530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F69530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Estimated impact of different combinations of options on breast and ovarian cancer risk in women with inherited genetic mutations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       Option combination",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"       Percent risk decrease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Breast cancer",
"      </td>",
"      <td class=\"subtitle2\">",
"       Ovarian cancer",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Prophylactic mastectomy and BSO before age 40",
"      </td>",
"      <td>",
"       &gt;90",
"      </td>",
"      <td>",
"       ~90",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       BSO before age 40 and tamoxifen",
"      </td>",
"      <td>",
"       ~85",
"      </td>",
"      <td>",
"       ~95",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       BSO before age 40 and breast cancer screening",
"      </td>",
"      <td>",
"       40 to 50",
"      </td>",
"      <td>",
"       ~95",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Breast cancer screening and ovarian cancer screening*",
"      </td>",
"      <td>",
"       0",
"      </td>",
"      <td>",
"       0",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BSO: bilateral salpingooophorectomy.",
"     <br>",
"      * Screening does not affect the risk of developing cancer but may affect the risk of dying from the cancer by detecting it early. Screening for ovarian cancer is difficult and has not been shown to affect the risk of dying of ovarian cancer. Breast cancer screening saves lives in women with average risk of breast cancer but has not been studied enough in women with genetic mutations to determine its effect on breast cancer mortality.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20155=[""].join("\n");
var outline_f19_43_20155=null;
var title_f19_43_20156="Risk primary brain tumors";
var content_f19_43_20156=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F69121&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F69121&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Factors studied in relationship to risk of primary brain tumors of neuroepithelial tissue or meninges",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Hereditary syndromes*: tuberous sclerosis, neurofibromatosis types 1 and 2,",
"nevoid basal cell carcinoma syndrome, and adenomatous",
"polyposis syndromes, Li-Fraumeni cancer family syndrome (inherited p53",
"mutations).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Family history of brain tumors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Constitutive",
"polymorphisms  in glutathione transferases, cytochrome p450 2D6 and",
"1A1, N-acetyltransferase, ERCC1 and ERCC2, other",
"carcinogen metabolizing, DNA repair, and immune function genes.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphocyte mutagen sensitivity to gamma radiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prior cancers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infectious agents or immunologic response:  viruses (common colds, influenza, varicellazoster virus, BK virus, JC",
"virus, others), Toxoplasma gondii",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allergies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Head trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epilepsy, seizures, or convulsions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drugs and medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diet and vitamins: nitrosamine/nitrosamide/nitrate/nitrite consumption,",
"cured foods, calcium, food frequency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tobacco smoke exposures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alcohol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hair dyes and hairsprays",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Traffic-related air pollution",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Occupations",
"and industries:  synthetic rubber manufacturing, vinyl chloride,",
"petroleum refining/production work, licensed",
"pesticide applicators, agricultural work, others (see text), parental",
"workplace exposures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ionizing radiation: therapeutic*; diagnostic and other sources",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cellular telephones",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other radiofrequency exposures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lower frequency",
"electromagnetic field",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ERCC2: Excision repair cross complementation group 2 gene, complementation group 2 (xerodema pigmentosum D).",
"     <br>",
"      * These are the only factors that have been proven to cause primary brain tumors of neuroepithelial tissue or meninges. Evidence for or against associations of other factors is presented in the text.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wrensch, M, Minn, Y, Chew, T, et al. Epidemiology of primary brain tumors: Current concepts and review of the literature. Neuro-Oncology 2002; 4:278. Copyright &copy; 2002 Margaret Wrensch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20156=[""].join("\n");
var outline_f19_43_20156=null;
var title_f19_43_20157="Lung cancer TMN staging 6th edition";
var content_f19_43_20157=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74820&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74820&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    AJCC TNM staging system for lung cancer (6th edition, 2002)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"4\">",
"       Primary tumor (T)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1",
"      </td>",
"      <td colspan=\"3\">",
"       Tumor &le;3 cm diameter without invasion more proximal than lobar bronchus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"4\">",
"       T2",
"      </td>",
"      <td class=\"sublist1_start\" colspan=\"3\">",
"       Tumor &gt;3 cm diameter",
"       <strong>",
"        OR",
"       </strong>",
"       Tumor of any size with any of the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Invades visceral pleura",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Atelectasis of less than entire lung",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Proximal extent at least 2 cm from carina",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"5\">",
"       T3",
"      </td>",
"      <td class=\"sublsit1_start\" colspan=\"3\">",
"       Tumor of any size with any of the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Invasion of chest wall",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Involvement of diaphragm, mediastinal pleura, or pericardium",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Atelectasis involving entire lung",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Proximal extent within 2 cm of carina",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"7\">",
"       T4",
"      </td>",
"      <td class=\"sublist1_start\" colspan=\"3\">",
"       Tumor of any size with any of the following:",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Invasion of mediastinum",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Invasion of heart or great vessels",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Invasion of trachea or esophagus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Invasion of vertebral body or carina",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Presence of malignant pleural or pericardial effusion",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\" colspan=\"3\">",
"       Satellite tumor nodule(s) within same lobe as primary tumor",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"4\">",
"       Nodal involvement (N)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N0",
"      </td>",
"      <td colspan=\"3\">",
"       No regional node involvement",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N1",
"      </td>",
"      <td colspan=\"3\">",
"       Metastasis to ipsilateral hilar and/or ipsilateral peribronchial nodes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N2",
"      </td>",
"      <td colspan=\"3\">",
"       Metastasis to ipsilateral mediastinal and/or subcarinal nodes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N3",
"      </td>",
"      <td colspan=\"3\">",
"       Metastasis to contralateral mediastinal or hilar nodes",
"       <strong>",
"        OR",
"       </strong>",
"       ipsilateral or contralateral scalene or supraclavicular nodes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"4\">",
"       Metastasis (M)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M0",
"      </td>",
"      <td colspan=\"3\">",
"       Distant metastasis absent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M1",
"      </td>",
"      <td colspan=\"3\">",
"       Distant metastasis present (includes metastatic tumor nodules in a different lobe from the primary tumor)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"4\">",
"       Stage groupings of TNM subsets",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage IA",
"      </td>",
"      <td>",
"       T1",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage IB",
"      </td>",
"      <td>",
"       T2",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage IIA",
"      </td>",
"      <td>",
"       T1",
"      </td>",
"      <td>",
"       N1",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Stage IIB",
"      </td>",
"      <td>",
"       T2",
"      </td>",
"      <td>",
"       N1",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T3",
"      </td>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Stage IIIA",
"      </td>",
"      <td>",
"       T3",
"      </td>",
"      <td>",
"       N1",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1-3",
"      </td>",
"      <td>",
"       N2",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Stage IIIB",
"      </td>",
"      <td>",
"       Any T",
"      </td>",
"      <td>",
"       N3",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T4",
"      </td>",
"      <td>",
"       Any N",
"      </td>",
"      <td>",
"       M0",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stage IV",
"      </td>",
"      <td>",
"       Any T",
"      </td>",
"      <td>",
"       Any N",
"      </td>",
"      <td>",
"       M1",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: AJCC Cancer Staging Manual, 6th edition, New York, 2002.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20157=[""].join("\n");
var outline_f19_43_20157=null;
var title_f19_43_20158="Adenoid cystic carcinoma CXR";
var content_f19_43_20158=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F81685&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F81685&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Adenoid cystic carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 320px; height: 322px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lateral view of the neck shows a posterior cervical tracheal wall lesion. The patient had been treated for atypical asthma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20158=[""].join("\n");
var outline_f19_43_20158=null;
var title_f19_43_20159="T piece adapter";
var content_f19_43_20159=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F76022&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F76022&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    T-piece adapter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 258px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f19_43_20159=[""].join("\n");
var outline_f19_43_20159=null;
